Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009340	s-metnor	— (—)	4215	5370	100.00%	Distribution not available
3009340	s-metnor	nmol/l (nmol/l)	772	999	99.90%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary hypertension

263

151

18.56

322.53

1.4

1.2

—

nmol/l

—

Benign neoplasm: Adrenal gland

899

223

60.36

307.65

1.4

1.3

—

nmol/l

—

Benign neoplasm: Adrenal gland

899

237

56.77

307.65

1.4

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified endocrine glands

1011

437

28.61

307.65

1.5

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified endocrine glands

1011

416

30.06

307.65

1.5

1.2

—

nmol/l

—

Headache

867

2345

3.14

197.13

1.3

—

nmol/l

—

Hyperaldosteronism

145

21.96

188.37

1.3

1.2

—

nmol/l

—

Other heart diseases

576

984

3.92

169.88

1.3

1.2

—

nmol/l

—

Abnormalities of breathing

1056

2335

2.72

169.83

1.3

—

nmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

448

1072

4.13

158.89

1.3

—

nmol/l

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

44.68

149.93

4.3

1.2

—

nmol/l

—

Medical observation and evaluation for suspected diseases and conditions

836

1494

2.90

143.73

1.3

—

nmol/l

—

Other disorders of adrenal gland

143

127

12.21

138.89

3.1

1.2

—

nmol/l

—

Anaemias

250

264

6.39

125.59

1.2

—

nmol/l

—

Hypokalaemia

225

394

5.94

123.03

1.2

1.3

—

nmol/l

—

Hypothyroidism (congenital or acquired)

281

289

5.66

117.88

1.4

1.2

—

nmol/l

—

Malignant neoplasm of adrenal gland

85.13

117.42

4.7

1.2

—

nmol/l

—

Hypothyroidism and >3 levothyroxin purchases

272

286

5.54

111.94

1.4

1.2

—

nmol/l

—

Hypothyroidism, levothyroxine purchases

272

286

5.54

111.94

1.4

1.2

—

nmol/l

—

Cerebrovascular diseases (FINNGEN)

356

651

3.97

110.07

1.4

1.2

—

nmol/l

—

Hypertensive heart and/or renal disease

282

477

4.66

109.39

1.3

1.2

—

nmol/l

—

Adrenomedullary hyperfunction

122.96

105.08

5.9

1.1

—

nmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

292

464

4.48

103.81

1.3

1.2

—

nmol/l

—

Hyperhidrosis

105

12.51

103.63

1.2

1.1

—

nmol/l

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

191

356

5.63

98.05

3.1

1.3

—

nmol/l

—

Hypertensive Heart Disease

239

431

4.61

93.44

1.3

1.2

—

nmol/l

—

Other soft tissue disorders, not elsewhere classified

970

2843

2.13

93.41

1.2

1.3

—

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

114

131

9.22

91.77

1.2

1.3

—

nmol/l

—

Atrial fibrillation and flutter

335

603

3.68

90.52

1.2

—

nmol/l

—

Pain in joint

611

1603

2.55

90.14

1.3

—

nmol/l

—

Cushing syndrome

22.59

85.01

1.2

1.1

—

nmol/l

—

Heart failure and antihypertensive medication

251

386

4.36

84.90

1.3

—

nmol/l

—

Paroxysmal tachycardia

244

515

4.07

82.49

1.3

1.2

—

nmol/l

—

Hypothyroidism, drug reimbursement

152

175

6.30

78.20

1.5

1.2

—

nmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

655

1493

2.35

77.15

1.3

—

nmol/l

—

Pure hypercholesterolaemia

718

2209

2.20

77.03

1.3

—

nmol/l

—

Atrial fibrillation and flutter with reimbursement

268

463

3.76

74.40

1.3

—

nmol/l

—

Pain in limb

780

2732

2.08

74.11

1.2

1.3

—

nmol/l

—

Other CVD (FINNGEN)

135

175

6.21

71.22

1.4

1.2

—

nmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

353

558

3.20

71.21

1.3

—

nmol/l

—

Nausea and vomiting

297

943

3.14

71.20

1.3

—

nmol/l

—

Disorders of thyroid, IBD co-morbidities

195

340

4.24

66.33

1.2

—

nmol/l

—

Syncope and collapse

428

1533

2.50

65.34

1.3

—

nmol/l

—

Malignant neoplasm of endocrine gland

143

305

4.89

62.98

3.1

1.2

—

nmol/l

—

Migraine

489

1839

2.28

60.61

1.2

1.3

—

nmol/l

—

Fever of other and unknown origin

485

1997

2.27

60.45

1.4

1.3

—

nmol/l

—

Benign neoplasm: Carotid body

56.32

59.84

4.5

1.2

—

nmol/l

—

Disorders of parathyroid gland

256

840

3.07

58.73

1.3

1.2

—

nmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

627

1494

2.14

58.54

1.3

—

nmol/l

—

Hyperparathyroidism

229

719

3.21

56.78

1.3

1.2

—

nmol/l

—

Pain, not elsewhere classified

287

1037

2.81

56.56

1.4

1.3

—

nmol/l

—

Hypopituitarism

102

182

5.78

54.75

1.4

1.1

—

nmol/l

—

Non-invasive ventilation

213

621

3.26

54.03

1.5

1.2

—

nmol/l

—

Anxiety disorders, excluding more controls

818

2972

1.84

53.53

1.3

—

nmol/l

—

Adrenocortical insufficiency

106

7.55

52.11

1.7

1.2

—

nmol/l

—

Heart failure, not strict

723

2661

1.89

51.86

1.3

—

nmol/l

—

Hyperlipidaemia, other/unspecified

360

1442

2.39

50.63

1.3

—

nmol/l

—

Asthma, unspecified (mode), excluding more controls

494

1844

2.12

50.43

1.3

—

nmol/l

—

Other specific joint derangements/joint disorders

701

2514

1.88

49.65

1.3

—

nmol/l

—

Persons encountering health services in other circumstances

390

1730

2.28

49.62

1.2

1.3

—

nmol/l

—

Asthma, unspecified (mode)

498

1950

2.04

46.07

1.3

—

nmol/l

—

Hypo-osmolality and hyponatraemia

184

583

3.20

45.75

1.3

—

nmol/l

—

Oedema, not elsewhere classified

283

1140

2.50

44.37

1.3

—

nmol/l

—

Hernia of abdominal wall, postoperative

165

508

3.29

43.22

1.4

1.2

—

nmol/l

—

Symptoms and signs concerning food and fluid intake

122

311

4.00

42.46

1.3

—

nmol/l

—

Chronic kidney disease

261

1044

2.52

41.67

1.4

1.3

—

nmol/l

—

Vocal cord dysfunction

139

368

3.56

40.34

1.4

1.2

—

nmol/l

—

Concussion

413

1751

2.06

39.83

1.2

1.3

—

nmol/l

—

Hypertensive Renal Disease

9.34

39.67

1.4

1.2

—

nmol/l

—

Fibromyalgia

124

339

3.75

39.26

1.2

—

nmol/l

—

Intracranial trauma

473

1808

1.97

39.26

1.2

1.3

—

nmol/l

—

Endocrine disorders, other/unspecified

9.05

37.36

2.0

1.2

—

nmol/l

—

Renal failure

365

1618

2.08

36.68

1.3

—

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

179

4.80

36.16

1.6

1.2

—

nmol/l

—

Continuous positive airway pressure

168

493

2.97

35.91

1.2

1.3

—

nmol/l

—

Spinal stenosis

441

1789

1.95

35.86

1.3

—

nmol/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

130

393

3.37

35.29

1.4

1.3

—

nmol/l

—

Anxiety (asthma-related co-morbidities)

549

2418

1.80

35.22

1.3

—

nmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

484

1848

1.89

35.12

1.4

1.2

—

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

184

4.67

34.98

1.6

1.3

—

nmol/l

—

Dysphagia

218

877

2.52

34.88

1.3

—

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

121

355

3.48

34.47

1.5

1.3

—

nmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

377

1219

2.04

33.70

1.3

—

nmol/l

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

86.16

33.63

2.6

1.3

—

nmol/l

—

Recurrent or chronic depression

380

1375

2.01

33.41

1.2

1.3

—

nmol/l

—

Infections, IBD-co-morbidities

132

288

3.37

33.16

1.4

1.2

—

nmol/l

—

Rheumatism, unspecified

171

629

2.77

32.95

1.2

1.3

—

nmol/l

—

Migraine without aura

194

760

2.58

32.85

1.3

1.2

—

nmol/l

—

Disorders of mineral metabolism

102

277

3.77

32.68

1.3

—

nmol/l

—

Benign neoplasm: Carotid body

61.92

31.73

4.5

1.2

—

nmol/l

—

Ischaemic heart disease, wide definition

678

2566

1.66

31.43

1.3

—

nmol/l

—

Other symptoms and signs involving the digestive system and abdomen

166

620

2.71

31.01

1.3

—

nmol/l

—

Hard cardiovascular diseases

687

2692

1.65

30.85

1.4

1.3

—

nmol/l

—

Ischemic heart diseases

682

2601

1.65

30.79

1.3

—

nmol/l

—

Phakomatoses, not elsewhere classified

10.52

30.73

3.4

1.4

—

nmol/l

—

Migraine with aura

220

943

2.36

30.66

1.2

—

nmol/l

—

Haemorrhage from respiratory passages

258

1092

2.21

30.53

1.3

—

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

306

918

2.13

30.37

1.2

—

nmol/l

—

Other endocrine disorders

131

4.97

29.89

1.8

1.2

—

nmol/l

—

Clear cell adenocarcinoma of kidney

147

4.79

29.62

1.3

—

nmol/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

148

4.76

29.38

1.3

1.2

—

nmol/l

—

Disorders of calcium metabolism

202

4.12

29.32

1.3

—

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis

102

301

3.46

28.88

1.5

1.3

—

nmol/l

—

Malignant neoplasm of urinary organs

106

322

3.36

28.66

1.5

1.3

—

nmol/l

—

Hypotension

150

558

2.73

28.29

1.4

1.3

—

nmol/l

—

Other CVD

171

688

2.52

27.50

1.4

1.3

—

nmol/l

—

Temporomandibular joint disorders

145

545

2.69

26.80

1.3

—

nmol/l

—

Abnormal weight loss

106

337

3.22

26.68

1.3

—

nmol/l

—

Benign neoplasm: Colon

405

1723

1.81

26.60

1.4

1.2

—

nmol/l

—

Abnormal findings on diagnostic imaging of other body structures

145

549

2.69

26.54

1.4

1.3

—

nmol/l

—

Oxycodone

291

1428

1.99

26.27

1.3

—

nmol/l

—

Other gastritis (incl. Duodenitis)

204

911

2.26

25.95

1.2

1.3

—

nmol/l

—

Myalgia

211

966

2.21

25.27

1.3

—

nmol/l

—

Weight loss

110

373

3.01

24.80

1.3

—

nmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

499

2730

1.66

24.65

1.4

1.3

—

nmol/l

—

Diaphragmatic hernia

318

1710

1.88

24.33

1.3

—

nmol/l

—

Cough

303

1536

1.91

24.25

1.3

1.2

—

nmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

439

2119

1.72

24.18

1.3

—

nmol/l

—

Chronic pancreatitis

127

473

2.73

24.04

1.4

1.3

—

nmol/l

—

Viral Sepsis

165

703

2.37

23.49

1.3

—

nmol/l

—

Non-rheumatic valve diseases

371

1520

1.79

23.34

1.4

1.3

—

nmol/l

—

Implicit viral Sepsis

164

701

2.37

23.19

1.3

—

nmol/l

—

Valvular heart disease excluding rheumatic fever

371

1528

1.79

23.03

1.4

1.3

—

nmol/l

—

Paralytic ileus and intestinal obstruction

204

963

2.14

22.63

1.3

—

nmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

733

3068

1.50

22.38

1.4

1.3

—

nmol/l

—

733

3068

1.50

22.38

1.4

1.3

—

nmol/l

—

Disorder of lipoprotein metabolism, unspecified

118

444

2.69

21.90

1.5

1.3

—

nmol/l

—

COPD (mode)

253

1028

1.97

21.60

1.3

—

nmol/l

—

Other disorders of kidney and ureter

127

506

2.55

21.05

1.4

1.3

—

nmol/l

—

Personality disorders, excluding more controls

215

1067

2.03

20.92

1.2

1.3

—

nmol/l

—

Non-selective monoamine reuptake inhibitors

332

1840

1.76

20.76

1.3

—

nmol/l

—

Polyarthropathies

536

2278

1.58

20.51

1.2

1.3

—

nmol/l

—

Heart failure,strict

405

1746

1.68

20.47

1.3

—

nmol/l

—

Disorders of synovium and tendon

424

2338

1.64

20.25

1.2

1.3

—

nmol/l

—

Other general symptoms and signs

130

4.19

20.19

1.3

—

nmol/l

—

Ovarian cyst

333

1081

1.79

20.07

1.3

1.2

—

nmol/l

—

Convulsions, not elsewhere classified

174

800

2.16

20.01

1.3

—

nmol/l

—

Care involving dialysis

272

3.11

19.94

1.3

—

nmol/l

—

Coronary atherosclerosis

542

2255

1.56

19.65

1.3

—

nmol/l

—

Disorders of adrenal gland, other and/or unspecified

15.33

19.64

1.6

1.2

—

nmol/l

—

Implicit bacterial Sepsis

292

1495

1.80

19.59

1.3

—

nmol/l

—

Benign neoplasm: Colon

408

2455

1.64

19.51

1.4

1.3

—

nmol/l

—

Extracorporeal dialysis

186

3.57

19.45

1.4

1.3

—

nmol/l

—

Drug-induced adrenocortical insufficiency

5.93

19.20

1.8

1.3

—

nmol/l

—

Substance abuse, excluding more controls

414

2246

1.62

18.75

1.3

—

nmol/l

—

Abnormal involuntary movements

125

523

2.42

18.69

1.3

—

nmol/l

—

Glomerular disorders in diseases classified elsewhere

108

422

2.60

18.69

1.2

1.3

—

nmol/l

—

COPD

336

1628

1.71

18.58

1.3

—

nmol/l

—

GI-bleeding

237

1268

1.88

18.55

1.3

—

nmol/l

—

Other and unspecified dermatitis

415

2596

1.61

18.53

1.3

—

nmol/l

—

Migraine without aura and triptan purchases

146

661

2.23

18.16

1.2

1.3

—

nmol/l

—

Other diseases of the digestive system

237

1279

1.87

18.08

1.3

—

nmol/l

—

Factors influencing health status and contact with health services

236

609

1.95

17.91

1.3

—

nmol/l

—

Dermatitis

482

3154

1.54

17.67

1.3

—

nmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

400

2074

1.61

17.64

1.2

1.3

—

nmol/l

—

Enlarged lymph nodes

129

563

2.31

17.52

1.3

—

nmol/l

—

Other enthesopathies

248

1373

1.82

17.46

1.2

1.3

—

nmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

207

1085

1.93

17.35

1.3

—

nmol/l

—

126

549

2.32

17.22

1.5

1.3

—

nmol/l

—

Heart failure, strict

428

1955

1.58

17.11

1.3

—

nmol/l

—

Gonarthrosis

522

1971

1.53

16.97

1.3

—

nmol/l

—

Other and unspecified urticaria

177

891

2.01

16.72

1.2

1.3

—

nmol/l

—

Nonorganic sleeping disorders, excluding more controls

149

704

2.14

16.68

1.2

1.3

—

nmol/l

—

Other chronic obstructive pulmonary disease

317

1573

1.69

16.63

1.3

—

nmol/l

—

Major coronary heart disease event excluding revascularizations

499

2277

1.52

16.52

1.4

1.3

—

nmol/l

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

10.64

16.44

2.8

1.2

—

nmol/l

—

Other or unspecified ileus, impaction or obstruction

140

650

2.17

16.37

1.3

—

nmol/l

—

Migraine with aura and triptan purchases

136

625

2.20

16.36

1.2

1.3

—

nmol/l

—

Other congenital malformations

313

2.72

16.02

2.1

1.3

—

nmol/l

—

Benign neoplasm: Pancreas

4.63

16.02

1.7

1.3

—

nmol/l

—

Intestinal stricture

238

1338

1.79

15.98

1.4

1.3

—

nmol/l

—

Elevated blood glucose level

298

2.76

15.88

1.2

1.3

—

nmol/l

—

All-cause Heart Failure

415

1919

1.57

15.86

1.3

—

nmol/l

—

Bacterial Sepsis

317

1716

1.65

15.65

1.3

—

nmol/l

—

Dialysis, with operation codes

111

478

2.35

15.64

1.3

—

nmol/l

—

Cluster headache, wide

126

3.81

15.54

1.4

1.5

—

nmol/l

—

Pacemaker

223

1207

1.81

15.39

1.3

—

nmol/l

—

Early onset COPD, excluding more controls

160

801

2.01

15.34

1.2

1.3

—

nmol/l

—

Gonarthrosis,primary

685

3064

1.41

15.31

1.2

1.3

—

nmol/l

—

Soft tissue disorders related to use, overuse and pressure

212

1167

1.83

15.29

1.2

1.3

—

nmol/l

—

Heartburn

344

2.59

15.28

1.2

1.4

—

nmol/l

—

Later onset COPD, excluding more controls

153

579

2.08

15.27

1.3

—

nmol/l

—

Unknown and unspecified causes of morbidity

233

2.96

15.19

1.2

1.3

—

nmol/l

—

Obesity, other/unspecified

272

1613

1.70

15.13

1.2

1.3

—

nmol/l

—

Postviral fatigue syndrome

7.59

15.03

1.6

1.3

—

nmol/l

—

Any operation in hilmo

6.23

14.95

1.6

1.0

—

nmol/l

—

Benign neoplasm: Pancreas

4.37

14.93

1.7

1.2

—

nmol/l

—

Transient ischemic attack

388

2077

1.56

14.81

1.3

—

nmol/l

—

Benign neoplasm: Endocrine pancreas

9.02

14.75

1.4

1.3

—

nmol/l

—

Major coronary heart disease event

536

2454

1.46

14.74

1.4

1.3

—

nmol/l

—

Epilepsy

214

1192

1.80

14.69

1.4

1.3

—

nmol/l

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

329

2.60

14.61

1.9

1.2

—

nmol/l

—

Acute renal failure

150

748

2.02

14.61

1.2

1.3

—

nmol/l

—

Other diseases of pancreas

272

2.77

14.58

1.3

—

nmol/l

—

COPD related to multimorbidity

271

1356

1.69

14.56

1.3

—

nmol/l

—

Intestinal malabsorption

166

3.33

14.56

1.1

1.2

—

nmol/l

—

Angina pectoris

455

2049

1.51

14.49

1.3

—

nmol/l

—

Osteoporosis

206

1095

1.81

14.21

1.4

1.3

—

nmol/l

—

Myocardial infarction, without ST-elevation

265

1466

1.68

14.00

1.4

1.3

—

nmol/l

—

Nephropathy related operations

105

465

2.29

13.92

1.3

—

nmol/l

—

Other symptoms and signs involving the circulatory and respiratory systems

181

3.14

13.87

1.4

1.3

—

nmol/l

—

Benign neoplasm: Endocrine pancreas

8.29

13.80

1.4

1.2

—

nmol/l

—

Algoneurodystrophy

128

3.61

13.72

1.2

1.4

—

nmol/l

—

Cerebral cysts

193

3.06

13.71

1.4

1.3

—

nmol/l

—

Myocardial infarction

369

1715

1.55

13.65

1.4

1.3

—

nmol/l

—

Hyperkalaemia

133

3.51

13.63

1.3

1.4

—

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

237

2.83

13.62

2.0

1.2

—

nmol/l

—

Other symptoms and signs involving the urinary system

347

2.48

13.55

1.3

—

nmol/l

—

Cluster headache, strict

115

3.73

13.52

1.4

1.5

—

nmol/l

—

Undetermined asthma, excluding more controls

104

464

2.26

13.51

1.2

—

nmol/l

—

Excessive, frequent and irregular menstruation

321

1109

1.62

13.48

1.3

—

nmol/l

—

Arthrosis

558

2146

1.43

13.41

1.3

—

nmol/l

—

Gastroduodenal ulcer

177

959

1.85

13.38

1.3

—

nmol/l

—

Aortic aneurysm

146

731

1.98

13.36

1.2

1.3

—

nmol/l

—

Mental and behavioural disorders due to tobacco

332

2.51

13.33

1.3

—

nmol/l

—

Missing teeth due to accident, extraction or parodontitis

103

463

2.25

13.21

1.3

1.2

—

nmol/l

—

Chronic gastritis

204

1163

1.77

13.16

1.3

—

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

242

2.77

13.11

2.0

1.3

—

nmol/l

—

Smoking dependency

335

2.48

13.09

1.3

—

nmol/l

—

Presence of other functional implants

418

1989

1.49

13.00

1.3

—

nmol/l

—

COPD, hospital admissions

315

1698

1.58

12.90

1.3

—

nmol/l

—

Cluster headache, wide,, including avohilmo

201

2.94

12.81

1.4

1.3

—

nmol/l

—

Adjustment and management of implanted device

130

647

2.03

12.80

1.3

—

nmol/l

—

COPD, early/later onset

317

1711

1.57

12.77

1.3

—

nmol/l

—

Cardiac arrest

3.72

12.75

1.4

1.3

—

nmol/l

—

Disorders resulting from impaired renal tubular function

120

3.59

12.74

1.3

1.4

—

nmol/l

—

COPD-related respiratory insufficiency

358

2.40

12.67

1.3

—

nmol/l

—

Undetermined asthma

104

477

2.20

12.66

1.2

—

nmol/l

—

Other symptoms and signs involving cognitive functions and awareness

300

1790

1.58

12.56

1.3

—

nmol/l

—

Sequelae with surgical and medical care as external cause

160

862

1.87

12.50

1.3

—

nmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

283

2.58

12.46

1.2

1.3

—

nmol/l

—

Benign neoplasm: Caecum

363

2.37

12.33

1.3

—

nmol/l

—

Abnormal findings on diagnostic imaging of lung

331

2110

1.54

12.28

1.3

—

nmol/l

—

Non-ischemic cardiomyopathy

207

984

1.74

12.28

1.3

—

nmol/l

—

Neuralgia and neuritis, unspecified

179

3.01

12.25

1.2

1.3

—

nmol/l

—

Other disorders of bladder

441

2.22

12.14

1.2

1.3

—

nmol/l

—

Collagenous colitis

354

2.38

12.09

1.2

1.3

—

nmol/l

—

Pain associated with micturition

101

468

2.18

12.06

1.3

—

nmol/l

—

Other disorders of white blood cells

182

2.96

11.91

1.2

—

nmol/l

—

Sicca syndrome [Sjögren]

401

2.28

11.87

1.3

—

nmol/l

—

Cluster headache, strict, including avohilmo

183

2.95

11.81

1.4

1.3

—

nmol/l

—

ILD medications: immunosuppressive drugs

457

3085

1.43

11.72

1.2

1.3

—

nmol/l

—

TMD related pain

127

3.38

11.70

1.3

1.2

—

nmol/l

—

Menorrhagia

287

996

1.60

11.64

1.3

1.2

—

nmol/l

—

Radiculopathy

123

622

1.99

11.63

1.4

1.3

—

nmol/l

—

Cardiodefibrillation

248

1546

1.61

11.41

1.3

—

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

268

1355

1.59

11.28

1.3

—

nmol/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

287

2.47

11.15

1.3

—

nmol/l

—

Ventral hernia

180

1045

1.73

11.00

1.4

1.3

—

nmol/l

—

Polyarthrosis

163

881

1.79

10.97

1.3

—

nmol/l

—

Nontoxic multinodular goitre

163

925

1.78

10.82

1.3

—

nmol/l

—

Disorders of vitreous body

362

2434

1.46

10.71

1.2

1.3

—

nmol/l

—

Malignant neoplasm of thyroid gland

288

2.43

10.62

1.9

1.3

—

nmol/l

—

Cardiomyopathy

122

636

1.93

10.60

1.3

—

nmol/l

—

Atypical facial pain

206

2.72

10.58

1.3

—

nmol/l

—

Other and unspecified polyneuropathies, also in other diseases

139

757

1.85

10.58

1.3

—

nmol/l

—

Myocarditis

3.67

10.52

1.5

1.3

—

nmol/l

—

Conduction disorders

187

916

1.71

10.51

1.3

—

nmol/l

—

AV-block

111

507

2.00

10.51

1.3

—

nmol/l

—

Paracetamol of NSAID medication

118

291

2.05

10.48

1.3

1.1

—

nmol/l

—

Stroke, including SAH

442

2323

1.41

10.47

1.4

1.3

—

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

144

798

1.82

10.36

1.5

1.3

—

nmol/l

—

Meniscus derangement

415

1994

1.43

10.34

1.3

—

nmol/l

—

Volume depletion

237

2.56

10.33

1.6

1.3

—

nmol/l

—

Hyperosmolality and hypernatraemia

5.78

10.30

1.3

1.2

—

nmol/l

—

Faecal incontinence

329

2.31

10.30

1.2

1.3

—

nmol/l

—

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

7.64

10.28

2.2

1.4

—

nmol/l

—

Unstable angina pectoris

256

1361

1.57

10.27

1.3

—

nmol/l

—

Unspecified/other endometriosis

361

2.24

10.26

1.2

—

nmol/l

—

Haemorrhage, not elsewhere classified

3.86

10.24

1.3

1.2

—

nmol/l

—

Hypoglycaemia, other or unspecified

233

2.57

10.20

1.1

1.3

—

nmol/l

—

Special screening examination for other diseases and disorders

245

2.51

10.15

1.2

—

nmol/l

—

Other noninflammatory disorders of uterus, except cervix

185

744

1.71

10.09

1.4

1.2

—

nmol/l

—

Immunodeficiencies

183

2.78

10.07

1.2

1.3

—

nmol/l

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

104

3.45

10.07

1.2

—

nmol/l

—

Oxicams

164

526

1.78

9.98

1.3

—

nmol/l

—

Adenomyosis (Endometriosis of uterus)

119

629

1.91

9.98

1.3

1.2

—

nmol/l

—

Stroke, excluding SAH

413

2173

1.42

9.98

1.4

1.3

—

nmol/l

—

Peripheral artery disease

280

1483

1.53

9.98

1.3

—

nmol/l

—

Benign neoplasm: Transverse colon

353

2.24

9.97

1.5

1.3

—

nmol/l

—

Benign neoplasm: Caecum

400

2.15

9.87

1.3

—

nmol/l

—

Otalgia

298

2.35

9.85

1.3

—

nmol/l

—

Neurofibromatosis, type 1

7.20

9.85

2.2

1.4

—

nmol/l

—

Other disorders of gingiva or/and edentulous alveolar ridge

152

2.94

9.84

1.6

1.2

—

nmol/l

—

Spondylolisthesis/Spondylolysis

136

755

1.81

9.76

1.2

1.3

—

nmol/l

—

Other arthrosis

375

1873

1.44

9.75

1.3

—

nmol/l

—

Benign neoplasm: Parathyroid gland

5.23

9.68

1.5

1.2

—

nmol/l

—

Other specified/unspecified soft tissue disorders

171

2.79

9.57

1.3

—

nmol/l

—

Other inflammation of eyelid

105

540

1.96

9.57

1.3

—

nmol/l

—

Deposits [accretions] on teeth

203

2.60

9.56

1.7

1.2

—

nmol/l

—

Combinations of oral blood glucose lowering drugs

193

1187

1.64

9.55

1.3

—

nmol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

151

834

1.75

9.50

1.1

1.2

—

nmol/l

—

Other specified/unspecified arthritis

199

1235

1.62

9.50

1.2

1.3

—

nmol/l

—

Neuroendocrine tumor and carcinoma of pancreas

6.97

9.49

2.2

1.4

—

nmol/l

—

Other diseases of intestine

426

2.08

9.48

1.4

1.3

—

nmol/l

—

Disorders of lens

500

2318

1.37

9.44

1.3

—

nmol/l

—

Benign neoplasm: Parathyroid gland

5.10

9.42

1.5

1.2

—

nmol/l

—

Diseases of male genital organs

334

1147

1.48

9.39

1.3

1.4

—

nmol/l

—

Thoracic aortic aneurysm

463

2.03

9.30

1.3

—

nmol/l

—

Other postsurgical states

220

2.53

9.30

1.6

1.3

—

nmol/l

—

Dental operations, only avohilmo

524

1982

1.36

9.24

1.3

—

nmol/l

—

COPD, hospital admission 2, with asthma infections

199

1055

1.62

9.22

1.3

—

nmol/l

—

Gout

169

921

1.68

9.22

1.2

1.3

—

nmol/l

—

Polyneuropathies and other disorders of the peripheral nervous system

150

873

1.73

9.18

1.3

—

nmol/l

—

Benign neoplasm: Spinal cord

4.92

9.14

2.9

1.2

—

nmol/l

—

Familial hypercholesterolemia

103

536

1.94

9.08

1.4

1.3

—

nmol/l

—

Dental operations

487

1830

1.37

9.07

1.3

—

nmol/l

—

Other diseases of stomach and duodenum

217

2.52

9.05

1.1

1.2

—

nmol/l

—

Benign neoplasm: Kidney

122

3.10

9.03

1.4

1.3

—

nmol/l

—

Trochanteric bursitis

107

567

1.90

8.95

1.2

1.3

—

nmol/l

—

Status epilepticus

3.42

8.93

1.6

1.3

—

nmol/l

—

Primary gonarthrosis, bilateral

357

2214

1.42

8.87

1.2

1.3

—

nmol/l

—

Other enthesopathy of foot (+metatarsalgia)

411

2.06

8.84

1.3

—

nmol/l

—

Gingival hyperplasia

3.33

8.80

1.6

1.2

—

nmol/l

—

Benign neoplasm: Kidney

124

3.05

8.78

1.4

1.3

—

nmol/l

—

Hyperfunction of pituitary gland

151

2.82

8.77

1.6

1.2

—

nmol/l

—

Unspecified kidney failure

282

2.29

8.75

1.3

—

nmol/l

—

Cerebral aneurysm, nonruptured

360

2.14

8.73

1.6

1.3

—

nmol/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

347

2.16

8.72

1.2

1.3

—

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

184

1145

1.61

8.71

1.4

1.2

—

nmol/l

—

Unspecified haematuria

266

1533

1.49

8.69

1.3

—

nmol/l

—

Benign neoplasm: Colon, unspecified

162

973

1.67

8.68

1.3

—

nmol/l

—

Asthma-related pneumonia or sepsis

236

1555

1.52

8.65

1.4

1.3

—

nmol/l

—

Asthma, hospital admissions 3, pneumonia

236

1555

1.52

8.65

1.4

1.3

—

nmol/l

—

Intestinal adhesions without obstruction

284

2.28

8.62

1.4

1.3

—

nmol/l

—

Benign neoplasm: Endocrine gland, other/unspecified

9.22

8.60

1.9

1.2

—

nmol/l

—

Metatarsalgia

382

2.09

8.60

1.3

—

nmol/l

—

Senile cataract

453

2067

1.36

8.53

1.2

1.3

—

nmol/l

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

195

2.36

8.52

1.5

1.2

—

nmol/l

—

Asthma-related pneumonia

235

1553

1.52

8.51

1.4

1.3

—

nmol/l

—

Heart failure and bmi 25plus

258

1188

1.50

8.45

1.3

—

nmol/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

6.07

8.43

1.0

1.4

—

nmol/l

—

Correction of physiology of bite - very demanding therapy visit

106

3.18

8.43

1.4

1.2

—

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

144

852

1.70

8.36

1.5

1.3

—

nmol/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

244

2.36

8.36

1.2

1.3

—

nmol/l

—

Psychotic depression

208

2.48

8.31

1.1

1.4

—

nmol/l

—

Chronic laryngitis and laryngotracheitis

109

596

1.84

8.31

1.3

—

nmol/l

—

Immunodeficiency with predominantly antibody defects

102

3.21

8.29

1.1

1.3

—

nmol/l

—

Abnormalities of gait and mobility

415

2.02

8.26

1.3

—

nmol/l

—

Gastric ulcer

115

640

1.81

8.26

1.3

—

nmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

212

1382

1.54

8.25

1.4

1.3

—

nmol/l

—

Hypoparathyroidism

118

3.02

8.24

1.3

1.2

—

nmol/l

—

Myocardial infarction, strict

313

1596

1.44

8.23

1.4

1.3

—

nmol/l

—

Benign neoplasm: Rectum

123

700

1.77

8.21

1.5

1.3

—

nmol/l

—

Other and unspecified disorders of vitreous body

301

2098

1.43

8.18

1.2

1.3

—

nmol/l

—

Oesophagitis

163

2.67

8.15

1.4

1.3

—

nmol/l

—

Early onset COPD

160

980

1.64

8.14

1.2

1.3

—

nmol/l

—

Benign neoplasm: Endocrine gland, other/unspecified

8.56

8.12

1.9

1.3

—

nmol/l

—

Problems related to lifestyle

377

2.06

8.12

1.3

—

nmol/l

—

Ischaemic Stroke, excluding all haemorrhages

371

2027

1.39

8.10

1.4

1.3

—

nmol/l

—

Retention of urine

200

1087

1.56

8.09

1.3

—

nmol/l

—

Cardiomyopathy, other and unspecified

273

2.26

8.08

1.3

—

nmol/l

—

Congenital malformations of the urinary system

199

2.49

8.08

1.4

1.3

—

nmol/l

—

Nonalcoholic fatty liver disease

392

2.04

8.06

1.2

1.3

—

nmol/l

—

Other disorders of eyelid

299

2028

1.43

8.00

1.2

1.3

—

nmol/l

—

Neuromuscular dysfunction of bladder

354

2.08

7.92

1.2

1.3

—

nmol/l

—

Cystic kidney disease

105

3.10

7.90

1.6

1.3

—

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

158

823

1.64

7.85

1.3

—

nmol/l

—

Pruritus

444

1.95

7.84

1.2

1.3

—

nmol/l

—

Other diseases of pleura

282

1741

1.44

7.79

1.3

—

nmol/l

—

Dissociative [conversion] disorders

133

2.82

7.77

1.6

1.3

—

nmol/l

—

Benign neoplasm: Transverse colon

391

2.02

7.75

1.5

1.3

—

nmol/l

—

Ocular pain

324

2.12

7.74

1.3

—

nmol/l

—

Other and unspecified drugs and medicaments

324

2.12

7.74

1.3

—

nmol/l

—

Postmenopausal osteoporosis with pathological fracture

248

2.29

7.66

1.2

1.3

—

nmol/l

—

Osteoporosis with pathological fracture (FG)

267

2.24

7.65

1.2

1.3

—

nmol/l

—

Hyperplasia of prostate

209

772

1.55

7.65

1.4

1.3

—

nmol/l

—

Crohn's disease NAS

229

2.34

7.65

1.2

1.3

—

nmol/l

—

Internal derangement of knee

261

1800

1.45

7.64

1.3

—

nmol/l

—

Other and unspecified disorders of white blood cells

135

2.79

7.58

1.2

—

nmol/l

—

Duodenal ulcer

327

2.10

7.54

1.5

1.3

—

nmol/l

—

Other specified/unspecified bacterial intestinal infections

244

2.28

7.48

1.5

1.3

—

nmol/l

—

Other diseases of liver

134

803

1.68

7.47

1.3

—

nmol/l

—

Diabetes insipidus

6.11

7.44

1.6

1.2

—

nmol/l

—

169

947

1.59

7.43

1.3

—

nmol/l

—

Rosacea

467

1.90

7.42

1.3

—

nmol/l

—

Later onset COPD

157

764

1.62

7.38

1.3

—

nmol/l

—

Benign neoplasm of urinary organs

161

2.58

7.29

1.4

1.2

—

nmol/l

—

Presence of cardiac and vascular implants and grafts

279

1482

1.43

7.27

1.3

—

nmol/l

—

Benign neoplasm: Sigmoid colon

122

719

1.71

7.25

1.5

1.3

—

nmol/l

—

Pulmonary embolism

192

1263

1.53

7.23

1.4

1.3

—

nmol/l

—

Laparoscopic right hemicolectomy

192

2.43

7.21

1.3

—

nmol/l

—

Persons encountering health services for specific procedures, not carried out

261

2.21

7.19

1.4

1.3

—

nmol/l

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

270

1666

1.43

7.17

1.6

1.2

—

nmol/l

—

Vascular disorders of the intestines

180

2.47

7.17

1.2

1.3

—

nmol/l

—

Pulmonary heart disease

192

1266

1.52

7.16

1.4

1.3

—

nmol/l

—

Restless leg syndrome

516

1.84

7.15

1.3

—

nmol/l

—

Other sleep disorders

382

1.98

7.14

1.4

1.3

—

nmol/l

—

Peripheral arterial reconstruction

552

1.80

7.13

1.3

—

nmol/l

—

Cardiac murmurs and other cardiac sounds

278

2.15

7.11

1.3

—

nmol/l

—

Nephrotic syndrome

101

3.02

7.11

1.1

1.3

—

nmol/l

—

Diplopia

518

1.83

7.06

1.4

1.3

—

nmol/l

—

Benign neoplasm of urinary organs

164

2.54

7.03

1.4

1.3

—

nmol/l

—

Other and unspecified abdominal hernia

135

2.71

7.02

1.2

1.3

—

nmol/l

—

Coxarthrosis

336

1659

1.38

6.98

1.3

—

nmol/l

—

Benign leiomyoma with endometriosis

131

796

1.66

6.97

1.2

—

nmol/l

—

Anankastic personality disorder

130

2.73

6.95

1.3

1.4

—

nmol/l

—

Dialysis

119

2.81

6.93

1.2

1.3

—

nmol/l

—

Benign neoplasm: Colon, unspecified

162

1038

1.57

6.92

1.3

—

nmol/l

—

Other specified/unspecified inflammatory spondylopathies

148

2.60

6.87

1.3

—

nmol/l

—

Benign neoplasm: Spinal cord

3.89

6.87

2.9

1.2

—

nmol/l

—

Other abnormal uterine and vaginal bleeding

173

795

1.56

6.84

1.2

—

nmol/l

—

Propionic acid derivatives

186

602

1.56

6.83

1.2

1.3

—

nmol/l

—

Benign neoplasm: Stomach

396

1.94

6.81

1.2

1.3

—

nmol/l

—

Disorders of pituitary gland, other and/or unspecified

7.45

6.76

1.5

1.3

—

nmol/l

—

Barrett oesophagus

132

2.69

6.75

1.1

1.2

—

nmol/l

—

Abdominal aortic aneurysm (AAA)

215

2.27

6.70

1.1

1.3

—

nmol/l

—

Abnormal results of function studies

330

2.02

6.66

1.4

1.3

—

nmol/l

—

Gout, FINNGEN

169

1106

1.54

6.58

1.2

1.3

—

nmol/l

—

Aneurysms, operations, SAH

116

695

1.68

6.54

1.5

1.3

—

nmol/l

—

Other and unspecified visual disturbances

374

1.94

6.53

1.2

1.3

—

nmol/l

—

Hydronephrosis

389

1.92

6.47

1.4

1.3

—

nmol/l

—

Acute pancreatitis

127

781

1.64

6.46

1.2

1.3

—

nmol/l

—

Viral pneumonia

475

1.82

6.45

1.3

—

nmol/l

—

Benign neoplasm: Rectum

123

752

1.65

6.42

1.5

1.3

—

nmol/l

—

Family history of other specific disorders

4.16

6.40

2.8

1.4

—

nmol/l

—

Autoimmune thyroiditis

3.80

6.40

1.1

1.2

—

nmol/l

—

Fungal Sepsis

102

2.88

6.39

1.4

1.2

—

nmol/l

—

Correction of physiology of bite - demanding therapy visit

288

2.07

6.38

1.4

1.3

—

nmol/l

—

122

704

1.65

6.37

1.3

—

nmol/l

—

Pure hyperglyceridaemia

3.51

6.32

1.3

1.5

—

nmol/l

—

Secondary polycythaemia

3.40

6.31

1.2

1.3

—

nmol/l

—

Spontaneous rupture of synovium and tendon

310

2.02

6.28

1.2

1.3

—

nmol/l

—

Cyst of kidney

237

2.18

6.27

1.3

—

nmol/l

—

Cerebral palsy and other paralytic syndromes

444

1.84

6.24

1.2

1.3

—

nmol/l

—

Viral hepatitis, IBD co-morbidity

109

2.77

6.21

1.5

1.2

—

nmol/l

—

Mixed hyperlipidaemia

115

2.73

6.20

1.2

1.4

—

nmol/l

—

Other aneurysm

150

2.49

6.20

1.5

1.2

—

nmol/l

—

Emphysema

193

2.30

6.20

1.5

1.3

—

nmol/l

—

Other and/or unspecified nontoxic goitre

347

1.95

6.16

1.3

—

nmol/l

—

Colectomy operation

113

684

1.66

6.15

1.4

1.3

—

nmol/l

—

Symptoms and signs involving appearance and behaviour

5.96

6.15

1.2

1.5

—

nmol/l

—

Neuroendocrine tumor and carcinoma of small intestine

4.22

6.14

1.2

—

nmol/l

—

Gout, idiopatic and unspecified

141

902

1.57

6.12

1.3

—

nmol/l

—

Glomerulonephritis

376

1.90

6.10

1.1

1.3

—

nmol/l

—

Diabetic nephropathy, excluding more controls

119

608

1.65

6.05

1.3

1.4

—

nmol/l

—

Polyglandular dysfunction

16.48

6.04

2.1

1.2

—

nmol/l

—

Autonomic disorders

3.30

6.04

1.5

1.3

—

nmol/l

—

Budesonide

560

1.73

6.01

1.3

—

nmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

221

2.19

6.01

1.2

—

nmol/l

—

Coxarthrosis [arthrosis of hip](FG)

360

1968

1.33

5.99

1.3

—

nmol/l

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

329

1.95

5.95

1.2

1.3

—

nmol/l

—

Gonarthrosis, primary, with knee surgery

367

2282

1.32

5.92

1.2

1.3

—

nmol/l

—

Gluteal tendinitis

118

2.66

5.92

1.2

1.3

—

nmol/l

—

Hyperkinetic disorders, excluding more controls

301

1.98

5.92

1.2

1.3

—

nmol/l

—

Other disorders of the musculoskeletal system and connective tissue

103

618

1.68

5.83

1.1

1.3

—

nmol/l

—

Diabetic nephropathy

122

755

1.61

5.80

1.3

1.4

—

nmol/l

—

Achilles tendinitis

405

1.84

5.77

1.2

1.3

—

nmol/l

—

Lateral epicondylitis

567

1.70

5.76

1.2

1.3

—

nmol/l

—

Rhinophyma

6.14

5.68

1.1

1.5

—

nmol/l

—

Other complications of surgical and medical care, not elsewhere classified

386

1.85

5.66

1.2

1.3

—

nmol/l

—

Degeneration of macula and posterior pole

290

1772

1.35

5.66

1.2

1.3

—

nmol/l

—

Acute gastritis

261

2.05

5.64

1.2

—

nmol/l

—

Other dialysis

2.84

5.60

1.2

1.4

—

nmol/l

—

Nonhereditary hypogammaglobulinemia

3.93

5.59

1.0

1.3

—

nmol/l

—

Benign leiomyoma with endometriosis

131

844

1.56

5.58

1.2

—

nmol/l

—

Spinal osteochondrosis

4.59

5.54

1.5

1.6

—

nmol/l

—

Carcinoid syndrome

4.95

5.54

1.3

1.2

—

nmol/l

—

N06DA Anticholinesterases

964

0.55

5.54

1.2

1.3

—

nmol/l

—

Use of anticholinesterases

964

0.55

5.54

1.2

1.3

—

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

182

1257

1.45

5.52

1.3

—

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

178

602

1.49

5.46

1.3

—

nmol/l

—

Viral pneumonia (unknown virus, not influenza)

231

2.10

5.44

1.3

—

nmol/l

—

Other and unspecified mononeuropathies of lower limb

2.85

5.43

1.1

1.3

—

nmol/l

—

Anaemia in chronic diseases classified elsewhere

3.07

5.40

1.1

1.3

—

nmol/l

—

Benign neoplasm: Sigmoid colon

122

779

1.58

5.40

1.5

1.3

—

nmol/l

—

Dermatographic urticaria

252

2.04

5.40

1.3

—

nmol/l

—

Implicit fungal Sepsis

2.77

5.39

1.2

—

nmol/l

—

Somnolence, stupor and coma

124

2.53

5.38

1.4

1.2

—

nmol/l

—

Malignant neoplasm of small intestine

3.15

5.38

1.2

1.3

—

nmol/l

—

Benign neoplasm: Stomach

430

1.78

5.35

1.2

1.3

—

nmol/l

—

Acidosis

3.61

5.35

1.6

1.5

—

nmol/l

—

Dental pulpitis 3

268

1.86

5.32

1.1

1.3

—

nmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

103

634

1.64

5.32

1.3

—

nmol/l

—

Benign neoplasm of middle ear and respiratory system

281

1.97

5.31

1.4

1.2

—

nmol/l

—

Scleritis and episcleritis

247

2.05

5.31

1.4

1.3

—

nmol/l

—

COPD, hospital admissions 1, only main diagnosis

202

1216

1.42

5.30

1.2

1.3

—

nmol/l

—

Peroneal tendinitis

3.92

5.29

1.1

1.3

—

nmol/l

—

Monoamine oxidase A inhibitors

536

1.69

5.28

1.5

1.3

—

nmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

268

2.00

5.27

1.4

1.3

—

nmol/l

—

Bipolar affective disorders

128

832

1.55

5.24

1.2

—

nmol/l

—

Preparatory care for dialysis

138

2.42

5.24

1.2

1.3

—

nmol/l

—

Eosinophilic disease (BM)

3.71

5.24

1.2

—

nmol/l

—

Hypertrophic cardiomyopathy

132

2.46

5.23

1.1

1.3

—

nmol/l

—

Mental and behavioural disorders due to opioids

126

2.49

5.22

1.4

1.3

—

nmol/l

—

Tuberous sclerosis 1

14.72

5.21

1.6

1.5

—

nmol/l

—

Heart failure and coronary heart disease

176

904

1.46

5.20

1.3

—

nmol/l

—

245

1693

1.37

5.19

1.3

—

nmol/l

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

151

2.35

5.19

1.2

1.3

—

nmol/l

—

Extreme obesity with alveolar hypoventilation

145

2.38

5.18

1.3

1.2

—

nmol/l

—

Abnormal serum enzyme levels

170

1159

1.45

5.17

1.3

—

nmol/l

—

L01XX Other antineoplastic agents

183

2.21

5.17

1.3

1.2

—

nmol/l

—

Impotence

145

2.37

5.16

1.4

—

nmol/l

—

Effects of other external causes

2.83

5.16

1.4

1.3

—

nmol/l

—

Sequelae of cerebrovascular disease

203

1268

1.41

5.16

1.3

—

nmol/l

—

Other disorders of nervous system

243

2.04

5.15

1.2

1.3

—

nmol/l

—

Thyrotoxicosis with toxic multinodular goitre

257

2.01

5.14

1.2

—

nmol/l

—

Alzheimer disease

780

0.54

5.11

1.2

1.3

—

nmol/l

—

Lactose intolerance, other/unspecified

2.88

5.11

2.0

1.4

—

nmol/l

—

Bruxism

3.14

5.10

1.3

1.2

—

nmol/l

—

Agoraphobia

2.69

5.09

1.1

1.3

—

nmol/l

—

Unspecified contracted kidney

5.49

5.09

1.2

1.7

—

nmol/l

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

3.65

5.09

1.2

—

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

227

1565

1.38

5.07

1.3

—

nmol/l

—

Vitamin D deficiency

3.23

5.07

1.3

—

nmol/l

—

Postmenopausal bleeding

200

772

1.43

5.07

1.2

—

nmol/l

—

Glaucoma

357

2436

1.29

5.06

1.2

1.3

—

nmol/l

—

Benign neoplasm of meninges

423

1.76

5.06

1.4

1.3

—

nmol/l

—

ILD medications: azathioprine

102

635

1.62

5.05

1.3

—

nmol/l

—

Ménière disease

402

1.78

5.01

1.4

1.3

—

nmol/l

—

Other shoulder lesions

351

1.84

5.01

1.1

1.3

—

nmol/l

—

Small fibre neuropathy

2.85

5.01

1.3

1.2

—

nmol/l

—

Benign lipomatous neoplasm

190

1349

1.41

5.01

1.3

1.2

—

nmol/l

—

Gout, strict definition

598

1.63

5.00

1.3

—

nmol/l

—

Unspecific neurodegenerative disorder

101

1100

0.63

4.99

1.2

1.3

—

nmol/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

274

1.95

4.97

1.6

1.3

—

nmol/l

—

Other or ill-defined heart diseases

154

2.29

4.96

1.7

1.3

—

nmol/l

—

Urethritis and urethral syndrome

2.91

4.95

1.5

1.2

—

nmol/l

—

Other diseases of the respiratory system

117

756

1.55

4.95

1.3

—

nmol/l

—

Other respiratory disorders and diseases

117

756

1.55

4.95

1.3

—

nmol/l

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.70

4.94

1.1

1.3

—

nmol/l

—

Other menopausal disorders

204

836

1.41

4.90

1.3

1.2

—

nmol/l

—

Actinic keratosis

217

1500

1.38

4.90

1.3

—

nmol/l

—

Hyperprolactinaemia

106

2.58

4.90

1.1

1.2

—

nmol/l

—

Congenital malformations of anterior segment of eye

4.42

4.87

1.6

1.4

—

nmol/l

—

Acute pancreatitis (for exclusion)

127

839

1.52

4.87

1.2

1.3

—

nmol/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

101

634

1.60

4.85

1.3

—

nmol/l

—

Other and unspecified diseases of blood and blood-forming organs

2.87

4.84

1.3

—

nmol/l

—

Conductive and sensorineural hearing loss

527

2973

1.23

4.84

1.3

—

nmol/l

—

Artificial joint re-operation

263

1.96

4.84

1.2

1.3

—

nmol/l

—

Gout, unspecified

112

721

1.56

4.83

1.3

—

nmol/l

—

Benign neoplasm of middle ear and respiratory system

291

1.91

4.83

1.4

1.3

—

nmol/l

—

Benign neoplasm: Brain, infratentorial

5.20

4.83

3.9

1.5

—

nmol/l

—

Benign neoplasm: Cerebral meninges

385

1.78

4.82

1.4

1.3

—

nmol/l

—

Azathioprine

102

643

1.59

4.82

1.3

—

nmol/l

—

Lactose intolerance

2.70

4.76

1.9

1.4

—

nmol/l

—

Ganglion

138

933

1.49

4.74

1.3

—

nmol/l

—

Other Crohn's disease

266

1.93

4.68

1.2

1.3

—

nmol/l

—

Dystonia

225

2.02

4.67

1.5

1.2

—

nmol/l

—

Abnormal spermatozoa

374

1.78

4.67

1.5

1.3

—

nmol/l

—

Nontoxic single thyroid nodule

302

1.87

4.66

1.3

—

nmol/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.42

4.65

1.0

1.3

—

nmol/l

—

Other peripheral vertigo

375

1.77

4.64

1.2

1.3

—

nmol/l

—

Diseases of the myoneural junction and muscle

480

1.68

4.62

1.3

—

nmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

435

1.71

4.61

1.3

1.2

—

nmol/l

—

Pre-eclampsia superimposed on chronic hypertension

4.95

4.58

1.0

1.1

—

Other diseases of oesophagus

318

1.84

4.57

1.4

1.2

—

nmol/l

—

Vitamin deficiency

160

2.21

4.57

1.4

1.3

—

nmol/l

—

Vitamin deficiency, wide

160

2.21

4.57

1.4

1.3

—

nmol/l

—

Other disorders involving the immune mechanism, not elsewhere classified

2.59

4.57

1.1

1.3

—

nmol/l

—

Other abnormal findings of blood chemistry

154

2.23

4.55

1.1

1.3

—

nmol/l

—

Disorders of muscles

370

1.77

4.54

1.2

1.3

—

nmol/l

—

Female genital prolapse

211

884

1.38

4.53

1.3

1.2

—

nmol/l

—

Fitting and adjustment of other devices

206

1403

1.37

4.52

1.3

—

nmol/l

—

Other disorders of binocular movement

2.90

4.52

1.4

1.2

—

nmol/l

—

Gastrointestinal stromal tumor and sarcoma

3.51

4.51

1.9

1.3

—

nmol/l

—

Carcinoma in situ, bladder

2.68

4.51

1.0

1.3

—

nmol/l

—

Dental pulpitis 3, only avohilmo

245

1.83

4.51

1.1

1.3

—

nmol/l

—

Misadventures to patients during surgical and medical care

576

1.61

4.50

1.5

1.3

—

nmol/l

—

Other and unspecified trigeminal disorders

3.33

4.50

1.2

1.3

—

nmol/l

—

KRA_PSY_EATING, excluding more controls

234

1.97

4.49

1.4

1.2

—

nmol/l

—

Other diseases of gallbladder

142

2.28

4.49

1.3

1.2

—

nmol/l

—

Disorders of continuity of bone

394

1.74

4.48

1.2

1.3

—

nmol/l

—

Papilloedema, unspecified

2.97

4.46

1.3

—

nmol/l

—

Crohn's disease of small intestine

257

1.92

4.45

1.2

1.4

—

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

141

971

1.46

4.45

1.3

—

nmol/l

—

Other diseases of pericardium

130

2.33

4.44

1.6

1.3

—

nmol/l

—

Diseases of peritoneum

410

1.72

4.44

1.3

—

nmol/l

—

Any dementia

1039

0.64

4.40

1.2

1.3

—

nmol/l

—

Benign neoplasm: Nasopharynx

4.35

4.39

1.1

1.5

—

nmol/l

—

Follow-up examination after treatment for malignant neoplasms

308

1.83

4.39

1.7

1.2

—

nmol/l

—

Benign intracranial hypertension

4.33

4.38

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

359

1.76

4.37

1.3

—

nmol/l

—

Radial styloid tenosynovitis [de Quervain]

210

2.02

4.37

1.3

—

nmol/l

—

Galactorrhea

3.60

4.37

1.1

1.3

—

nmol/l

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

266

1581

1.32

4.37

1.4

1.2

—

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

137

942

1.46

4.36

1.8

1.3

—

nmol/l

—

Other and unspecified injuries of lower leg

273

1.88

4.36

1.0

1.3

—

nmol/l

—

Other/unspecified disorders of vestibular function

125

2.35

4.36

1.2

—

nmol/l

—

Benign neoplasm: Brain, infratentorial

4.72

4.35

3.9

1.6

—

nmol/l

—

Benign neoplasm of meninges

443

1.68

4.34

1.4

1.3

—

nmol/l

—

Alzheimer disease, including avohilmo

928

0.62

4.34

1.2

1.3

—

nmol/l

—

Sensorineural hearing loss

490

2809

1.22

4.33

1.3

—

nmol/l

—

Dementia, including avohilmo

132

1318

0.69

4.30

1.2

1.3

—

nmol/l

—

Other follicular disorders

246

1.93

4.30

1.3

—

nmol/l

—

Arthropathies in other diseases classified elsewhere

126

2.33

4.28

1.1

1.3

—

nmol/l

—

Magnesium deficiency

7.49

4.27

2.2

1.6

—

nmol/l

—

Other disorders of conjunctiva

569

1.59

4.26

1.2

1.3

—

nmol/l

—

TMD muscular pain linked with fibromyalgia

3.72

4.25

1.2

1.3

—

nmol/l

—

Kidney transplant status

172

2.11

4.24

1.4

1.3

—

nmol/l

—

Viral infections of the central nervous system

283

1.85

4.24

1.3

—

nmol/l

—

Pleural effusion

531

1.61

4.22

1.4

1.3

—

nmol/l

—

Benign neoplasm: Brain, supratentorial

3.32

4.21

2.1

1.3

—

nmol/l

—

Ovarian dysfunction, other/unspecified

7.18

4.21

1.3

1.2

—

nmol/l

—

Defects in the complement system

4.22

4.20

1.5

1.2

—

nmol/l

—

Benign neoplasm: Nasopharynx

4.19

1.1

1.5

—

nmol/l

—

Special screening examination for infectious and parasitic diseases

129

655

1.48

4.19

1.3

1.2

—

nmol/l

—

IgA nephropathy (IgA glomerulonephritis)

2.70

4.18

1.1

1.3

—

nmol/l

—

Familial hypercholesterolemia, with ischemic heart disease

306

1.81

4.17

1.3

—

nmol/l

—

Acute peritonitis

207

2.00

4.17

1.4

1.2

—

nmol/l

—

Other and unspecified injuries of ankle and foot

134

2.26

4.16

1.1

1.3

—

nmol/l

—

Pericarditis

109

2.41

4.16

1.7

1.3

—

nmol/l

—

Fentanyl

299

1.81

4.15

1.4

1.3

—

nmol/l

—

Arterial embolism and thrombosis

160

2.14

4.15

1.3

—

nmol/l

—

Benign neoplasm: Cerebral meninges

404

1.70

4.13

1.4

1.3

—

nmol/l

—

Isolated proteinuria with specified morphological lesion

3.84

4.11

1.5

1.4

—

nmol/l

—

Viral meningitis

135

2.25

4.10

1.1

1.3

—

nmol/l

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

3.29

4.10

1.9

1.3

—

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

107

710

1.51

4.09

1.6

1.3

—

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

102

670

1.53

4.09

1.3

1.2

—

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

405

1.69

4.08

1.3

—

nmol/l

—

Chronic periodontitis

591

1.56

4.08

1.5

1.3

—

nmol/l

—

Cauda equina syndrome

3.59

4.08

1.6

1.3

—

Benign neoplasm: Skin of eyelid, including canthus

103

679

1.53

4.07

1.3

—

nmol/l

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.48

4.07

1.3

1.1

—

nmol/l

—

Carcinoma in situ of other and unspecified sites

2.53

4.06

1.0

1.3

—

nmol/l

—

Otitis externa, unspecified

421

1.67

4.06

1.6

1.3

—

nmol/l

—

Other erythematous conditions

123

2.31

4.05

1.4

1.2

—

nmol/l

—

Any event in hilmo or specialist outpatient

+∞

4.04

2.2

0.0

—

nmol/l

—

Dementia

122

1221

0.69

4.04

1.2

1.3

—

nmol/l

—

Rash and other nonspecific skin eruption

407

1.68

4.02

1.3

—

nmol/l

—

Other orthopaedic follow-up care

210

1.97

4.02

1.3

—

nmol/l

—

Non-allergic asthma (mode), excluding more controls

112

746

1.49

4.01

1.2

—

nmol/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.03

4.01

1.3

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.02

4.01

1.1

—

Heart failure and hypertrophic cardiomyopathy

3.08

3.99

1.1

1.4

—

nmol/l

—

Alzheimer’s disease, wide definition

672

0.55

3.99

1.2

1.3

—

nmol/l

—

Carcinoma in situ, bladder

2.51

3.98

1.0

1.3

—

nmol/l

—

Benign neoplasm: Brain, supratentorial

3.18

3.95

2.1

1.3

—

nmol/l

—

Blepharochalasis

191

1419

1.35

3.93

1.2

1.3

—

nmol/l

—

Injury of unspecified body region

269

1.84

3.91

1.5

1.3

—

nmol/l

—

Speech disturbances, not elsewhere classified

306

1.78

3.89

1.3

1.2

—

nmol/l

—

Episcleritis

213

1.94

3.88

1.4

1.3

—

nmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

234

1.90

3.88

1.4

—

nmol/l

—

Other necrotizing vasculopathies (FG)

220

1.93

3.87

1.3

—

nmol/l

—

Causalgia

3.01

3.87

1.9

1.3

—

nmol/l

—

Degenerative diseases of the nervous system

929

0.64

3.85

1.2

1.3

—

nmol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

3.90

3.84

1.1

1.4

—

nmol/l

—

Iron deficiency

3.10

3.82

1.1

1.4

—

nmol/l

—

Panniculitis affecting regions of neck and back

120

2.27

3.81

1.3

1.4

—

nmol/l

—

conjunctival haemorrhage

286

1.80

3.81

1.1

1.3

—

nmol/l

—

Colorectal neuroendocrine tumor and carcinoma

3.25

3.80

1.4

—

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

368

1.70

3.80

1.5

1.3

—

nmol/l

—

Other specified disorders of kidney and ureter

114

2.31

3.80

2.2

1.2

—

nmol/l

—

Malignant neoplasm of pancreas

180

2.02

3.79

1.9

1.2

—

nmol/l

—

Other and unspecified erythematous conditions

108

2.34

3.78

1.4

1.3

—

nmol/l

—

Ethmoidectomy

555

1.56

3.77

1.2

1.3

—

nmol/l

—

Other skin changes

102

683

1.50

3.77

1.2

1.3

—

nmol/l

—

Intracerebral haemorrhage

407

1.65

3.76

1.4

1.2

—

nmol/l

—

Carrier of infectious disease

2.68

3.75

1.4

1.2

—

Lesion of ulnar nerve

572

1.55

3.74

1.3

—

nmol/l

—

Thyroiditis

288

1.78

3.73

1.2

1.3

—

nmol/l

—

Use of pramipexole

140

998

1.41

3.73

1.2

1.3

—

nmol/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

7.03

3.73

1.9

1.7

—

nmol/l

—

Crohn's disease of large intestine

195

1.97

3.73

1.1

1.3

—

nmol/l

—

Trigeminal neuralgia

216

1.91

3.73

1.2

1.3

—

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

325

1.73

3.73

1.1

1.3

—

nmol/l

—

Asthma mixed form (mode), excluding more controls

161

2.06

3.71

1.3

—

nmol/l

—

Decubitus ulcer and pressure area

168

2.04

3.70

1.1

1.3

—

nmol/l

—

Giant cell arteritis

142

2.14

3.66

1.3

1.2

—

nmol/l

—

Hirsutism in women

2.90

3.64

1.2

1.1

—

Atopic dermatitis, strict definition with reimbursement

187

1359

1.34

3.63

1.2

1.3

—

nmol/l

—

Other peripheral vascular diseases

298

1.76

3.63

1.4

1.3

—

nmol/l

—

Sulfonylureas

193

1156

1.34

3.62

1.4

1.3

—

nmol/l

—

Atopic conjunctivitis

163

2.04

3.61

1.2

1.3

—

nmol/l

—

Zoster [herpes zoster]

108

739

1.47

3.60

1.3

—

nmol/l

—

Polymyalgia rheumatica

506

1.57

3.60

1.2

1.3

—

nmol/l

—

Other noninflammatory disorders of vulva and perineum

390

1.65

3.58

1.3

1.2

—

nmol/l

—

Other disorders of penis

307

1.74

3.56

1.2

1.3

—

nmol/l

—

Fibroblastic disorders

131

931

1.41

3.56

1.2

1.3

—

nmol/l

—

Alzheimer’s disease (Late onset)

598

0.54

3.56

1.2

1.3

—

nmol/l

—

Other necrotizing vasculopathies

263

1.80

3.56

1.3

—

nmol/l

—

Cramp and spasm

164

2.03

3.56

1.2

1.3

—

nmol/l

—

Scleritis

3.11

3.56

1.1

1.3

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

540

1.55

3.54

1.3

1.2

—

nmol/l

—

Crohn disease (strict definition, require KELA)

242

1.83

3.53

1.4

—

nmol/l

—

Carcinoma in situ of other and unspecified sites

2.35

3.51

1.0

1.4

—

nmol/l

—

Exophthalmic conditions

3.62

3.50

1.0

1.3

—

nmol/l

—

Other factor of the environment

3.40

3.50

1.8

1.2

—

Glaucoma suspect

223

1725

1.30

3.49

1.2

1.3

—

nmol/l

—

Asthma mixed form (mode)

165

2.01

3.49

1.3

—

nmol/l

—

Traumatic subdural haemorrhage

364

1.65

3.46

1.1

1.4

—

nmol/l

—

Eosinophilia

2.81

3.44

1.2

—

nmol/l

—

Other coagulation defects

266

1.78

3.44

1.2

1.3

—

nmol/l

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

3.04

3.44

1.4

1.3

—

nmol/l

—

Poisoning by medicine, drug-induced

3.04

3.44

1.1

1.3

—

nmol/l

—

Dementia in Alzheimer disease

466

0.49

3.43

1.3

—

nmol/l

—

Temporal arteritis

126

2.17

3.43

1.4

1.2

—

nmol/l

—

Other otitis externa (chronic)

230

1.84

3.42

1.1

1.3

—

nmol/l

—

Other and unspecified rosacea

349

1.67

3.42

1.3

1.2

—

nmol/l

—

Non-allergic asthma (mode)

112

773

1.44

3.41

1.2

—

nmol/l

—

Invasive ventilation

252

1.80

3.41

1.7

1.3

—

nmol/l

—

Diseases of tongue

245

1.81

3.40

1.2

1.3

—

nmol/l

—

Other specified and unspecified retinal disorders

107

2.27

3.40

1.6

1.4

—

nmol/l

—

Respiratory insufficiency

230

1.83

3.39

1.4

1.3

—

nmol/l

—

Bronchiectasis

282

1.75

3.39

1.5

1.3

—

nmol/l

—

Benign neoplasm of bone and articular cartilage

327

1.69

3.39

1.2

1.3

—

nmol/l

—

Convergence insufficiency and excess

3.15

3.39

1.5

1.2

—

nmol/l

—

Endocarditis

101

2.30

3.37

1.7

1.3

—

nmol/l

—

Vascular diseases of the intestine

101

2.30

3.36

1.0

1.3

—

nmol/l

—

Benign neoplasm of bone and articular cartilage

328

1.69

3.36

1.2

—

nmol/l

—

FESS (DNB20)

531

1.53

3.36

1.2

1.3

—

nmol/l

—

Presence of other devices

119

841

1.42

3.35

1.2

1.3

—

nmol/l

—

Tobacco use

175

1.96

3.34

1.1

1.3

—

nmol/l

—

Other pleural conditions

321

1.69

3.33

1.2

1.3

—

nmol/l

—

Chronic conjunctivitis

108

2.25

3.33

1.3

1.4

—

nmol/l

—

Idiopathic urticaria

2.57

3.31

1.1

1.3

—

nmol/l

—

Psoriatic and enteropathic arthropathies

493

1.55

3.31

1.2

1.3

—

nmol/l

—

Chronic nephritic syndrome

128

2.13

3.31

1.2

1.3

—

nmol/l

—

Olecranon bursitis

204

1.88

3.30

1.2

1.3

—

nmol/l

—

Cholecystitis

501

1.54

3.30

1.3

—

nmol/l

—

Benign neoplasm: Descending colon

233

1.82

3.30

1.5

1.3

—

nmol/l

—

Benign neoplasm: Descending colon

233

1.82

3.30

1.5

1.3

—

nmol/l

—

Benign neoplasm: Small intestine

135

2.10

3.29

1.3

1.2

—

nmol/l

—

Allergic rhinitis

191

1446

1.31

3.29

1.2

1.3

—

nmol/l

—

Impacted cerumen

361

1.64

3.28

1.3

—

nmol/l

—

Use of other anti-dementia drugs

712

0.60

3.27

1.1

1.3

—

nmol/l

—

Use of memantine

712

0.60

3.27

1.1

1.3

—

nmol/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.82

3.27

1.5

1.3

—

nmol/l

—

Disorders of magnesium metabolism

4.88

3.27

1.3

1.2

—

nmol/l

—

Calcific aortic valvular stenosis, operated

147

1059

1.36

3.26

1.3

—

nmol/l

—

Calcific aortic valvular stenosis

147

1059

1.36

3.26

1.3

—

nmol/l

—

Examination and encounter for administrative purposes

122

2.15

3.26

1.2

1.3

—

nmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

156

2.01

3.25

1.1

1.3

—

nmol/l

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

286

1.73

3.25

1.3

1.2

—

nmol/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

5.61

3.24

1.9

1.6

—

nmol/l

—

Other disorders of central nervous system

3.22

3.23

1.2

1.5

—

nmol/l

—

Dependent personality disorder

2.54

3.23

1.2

1.3

—

Benign neoplasm: Brain, unspecified

5.49

3.22

1.3

1.2

—

nmol/l

—

Ulcerative ileocolitis

150

2.02

3.21

1.1

1.4

—

nmol/l

—

Pustulosis palmaris et plantaris

164

1.97

3.20

1.2

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified sites

110

2.21

3.20

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified sites

110

2.21

3.20

1.3

—

nmol/l

—

Patellar tendinitis

3.37

3.20

1.2

1.5

—

nmol/l

—

Other specified/unspecified dorsopathies

110

2.20

3.20

1.2

1.3

—

nmol/l

—

Benign lipomatous neoplasm

190

1460

1.31

3.17

1.3

—

nmol/l

—

Tongue abnormality

229

1.81

3.17

1.2

—

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

146

1058

1.35

3.14

1.3

—

nmol/l

—

Operations 2 for CAVS

146

1058

1.35

3.14

1.3

—

nmol/l

—

Hypertrichosis

2.57

3.14

1.2

—

Giant cell arteritis with polymyalgia rheumatica

131

2.08

3.14

1.4

1.2

—

nmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

444

1.56

3.13

1.2

1.3

—

nmol/l

—

Other immunodeficiencies

3.14

3.11

1.5

1.3

—

nmol/l

—

Factitial dermatitis

5.17

3.08

1.0

1.6

—

nmol/l

—

Benign neoplasm: Brain, unspecified

5.15

3.08

1.3

1.2

—

nmol/l

—

Benign neoplasm: Ascending colon

486

1.53

3.07

1.6

1.3

—

nmol/l

—

Hereditary motor and sensory neuropathy

3.53

3.07

1.3

1.4

—

nmol/l

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.24

3.07

2.4

1.3

—

nmol/l

—

Other and unspecified myopathies

291

1.69

3.07

1.4

1.3

—

nmol/l

—

Schizophrenia or delusion, excluding more controls

174

1317

1.31

3.07

1.3

—

nmol/l

—

Plantar fascial fibromatosis

407

1.58

3.06

1.2

1.3

—

nmol/l

—

Unspecified chronic bronchitis

2.24

3.06

1.1

1.3

—

Chondrocostal junction syndrome [Tietze]

146

2.01

3.06

1.6

1.3

—

nmol/l

—

Other abnormal immunological findings in serum

2.54

3.06

1.1

1.3

—

nmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

146

1062

1.35

3.06

1.3

—

nmol/l

—

Other disorders of pigmentation

153

1.98

3.05

1.4

1.3

—

nmol/l

—

Polycythaemia vera

119

2.12

3.05

1.1

1.3

—

nmol/l

—

Other neurotic disorders

174

1.91

3.05

1.5

1.3

—

nmol/l

—

Autoimmune hyperthyroidism

232

1.78

3.04

1.1

1.3

—

nmol/l

—

Myasthenia gravis

2.93

3.04

1.2

—

nmol/l

—

Other contact dermatitis

338

1.64

3.03

1.2

1.3

—

nmol/l

—

Visual impairment including blindness (binocular or monocular)

203

1.83

3.03

1.4

1.3

—

nmol/l

—

All influenza (not pneumonia)

601

1.47

3.03

1.4

1.3

—

nmol/l

—

Postmenopausal atrophic vaginitis

173

788

1.33

3.02

1.2

—

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

233

1.77

3.00

1.5

1.3

—

nmol/l

—

Other disorders of optic [2nd] nerve and visual pathways

211

1.81

3.00

1.2

1.3

—

nmol/l

—

Arterial embolism and thrombosis of lower extremity artery

2.36

2.99

1.3

1.2

—

nmol/l

—

Other abnormal findings in urine

3.05

2.99

2.4

1.2

—

nmol/l

—

Calcific tendinitis of shoulder

234

1.77

2.97

1.2

1.3

—

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

216

1705

1.27

2.95

1.3

—

nmol/l

—

Universal erythroderma, KELA reimbursement

3.19

2.94

1.2

1.3

—

nmol/l

—

Acromegaly and pituitary gigantism

4.83

2.94

1.1

1.2

—

Postprocedural disorders of digestive system, not elsewhere classified

108

2.15

2.91

1.0

1.2

—

nmol/l

—

Alcohol-induced chronic pancreatitis

228

1.77

2.91

1.4

1.3

—

nmol/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

142

1.99

2.91

1.1

1.2

—

nmol/l

—

Hallux rigidus

648

1.44

2.91

1.2

1.3

—

nmol/l

—

Entropion and trichiasis of eyelid

273

1.69

2.90

1.2

1.3

—

nmol/l

—

Ulcer of lower limb, not elsewhere classified

509

1.50

2.90

1.2

1.3

—

nmol/l

—

L04AD Calcineurin inhibitors

445

1.54

2.89

1.3

—

nmol/l

—

Benign neoplasm of ovary

119

867

1.38

2.89

1.3

1.2

—

nmol/l

—

Crohn disease (strict definition, all UC cases excluded)

185

1.85

2.88

1.4

1.3

—

nmol/l

—

Malignant neoplasm of rectosigmoid junction

2.97

2.87

1.0

1.3

—

nmol/l

—

Rheumatoid arthritis

195

1385

1.28

2.87

1.2

1.3

—

nmol/l

—

Chronic periodontitis, complicated

359

1.60

2.87

1.5

1.3

—

nmol/l

—

Polyp of the female genital tract

208

946

1.28

2.86

1.2

—

nmol/l

—

Benign neoplasm: Small intestine

143

1.98

2.86

1.3

1.2

—

nmol/l

—

Other congenital malformations of skin

143

1.98

2.86

1.1

1.2

—

nmol/l

—

Other noninflammatory disorders of vagina

336

1.62

2.86

1.3

1.2

—

nmol/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

267

1.70

2.85

1.4

1.3

—

nmol/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

298

1.65

2.84

1.2

1.3

—

nmol/l

—

Wet age-related macular degeneration

558

1.47

2.83

1.2

1.3

—

nmol/l

—

Other disorders starting during childhood or adolecense, excluding more controls

105

2.12

2.83

1.0

1.3

—

nmol/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.81

2.83

1.2

1.3

—

nmol/l

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

660

1.43

2.83

1.1

1.3

—

nmol/l

—

Trigger finger

594

1.45

2.82

1.1

1.3

—

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue

130

2.02

2.81

1.5

1.3

—

nmol/l

—

Other and unspecified mononeuropathies, also in other diseases

2.24

2.81

1.3

—

nmol/l

—

Calculus of lower urinary tract

151

1.93

2.80

1.1

1.3

—

nmol/l

—

Congenital malformations of uterus and cervix

2.57

2.80

1.6

1.2

—

nmol/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

307

1.64

2.79

1.5

1.3

—

nmol/l

—

Sleep disorders, other/unspecified

110

2.11

2.79

1.2

1.3

—

nmol/l

—

Benign neoplasm: Vulva

2.29

2.79

1.5

1.2

—

nmol/l

—

Relapsing fevers

8.80

2.79

1.4

1.0

—

Infection of intervertebral disc (pyogenic)

3.28

2.79

1.2

1.4

—

nmol/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

8.75

2.78

1.2

2.0

—

nmol/l

—

Other and unspecified disorders of autonomic nervous system

5.20

2.76

1.4

1.5

—

nmol/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

145

1.95

2.76

1.1

1.3

—

nmol/l

—

Anosmia

3.04

2.75

1.3

1.0

—

nmol/l

—

Allergic contact dermatitis

614

1.44

2.75

1.1

1.2

—

nmol/l

—

Other adrenocortical overactivity

5.13

2.75

1.1

1.3

—

nmol/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

278

1.66

2.74

1.2

1.3

—

nmol/l

—

Abnormal findings on diagnostic imaging of breast

2.64

2.72

1.2

—

Benign neoplasm: Anus and anal canal

2.17

2.72

1.5

1.3

—

nmol/l

—

Subacute thyroiditis

132

1.99

2.71

1.2

—

nmol/l

—

Hypotension due to drugs

3.02

2.71

1.4

1.2

—

nmol/l

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

542

1.46

2.70

1.2

1.3

—

nmol/l

—

Anuria and oliguria

4.32

2.70

1.0

1.5

—

nmol/l

—

Other secondary gonarthrosis

182

1.83

2.70

1.1

1.3

—

nmol/l

—

Amenorrhoea

234

1.72

2.68

1.5

1.2

—

nmol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

138

618

1.34

2.67

1.3

—

nmol/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

382

1.55

2.66

1.4

1.3

—

nmol/l

—

Seborrhoeic dermatitis

382

1.55

2.66

1.4

1.3

—

nmol/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

3.18

2.66

1.3

—

nmol/l

—

Benign neoplasm: Anus and anal canal

2.15

2.66

1.5

1.2

—

nmol/l

—

Ulcerative enterocolitis

2.14

2.65

1.3

—

nmol/l

—

Nontraumatic intracranial haemmorrhage

105

761

1.38

2.65

1.4

1.3

—

nmol/l

—

Congenital malformations of eye, ear, face and neck

235

1.71

2.65

1.5

1.3

—

nmol/l

—

Hypersomnia

2.70

2.64

1.4

—

nmol/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.69

2.64

1.2

1.3

—

nmol/l

—

Hypertensive encephalopathy

4.87

2.63

1.1

1.7

—

nmol/l

—

Infective dermatitis

480

1.49

2.63

1.5

1.3

—

nmol/l

—

Striae atrophicae

2.95

2.60

1.2

1.3

—

nmol/l

—

Migraine with aura, drug-induced

2.95

2.60

1.4

1.2

—

nmol/l

—

Benign neoplasm: Vulva

2.21

2.59

1.5

1.2

—

nmol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

409

1.52

2.58

1.3

—

nmol/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

706

1.39

2.58

1.3

—

nmol/l

—

Renal cell carcinoma of kidney

107

2.07

2.58

2.4

1.2

—

nmol/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

260

1.67

2.58

1.1

1.3

—

nmol/l

—

Any dementia, excluding more controls

889

0.72

2.57

1.2

1.3

—

nmol/l

—

Peripheral artery operations in Hilmo

385

1.54

2.57

1.2

1.3

—

nmol/l

—

Perioral dermatitis

2.38

2.57

1.3

1.2

—

nmol/l

—

Hidradenitis suppurativa

121

2.00

2.56

1.3

—

nmol/l

—

Other facial nerve disorders

2.15

2.56

1.3

—

nmol/l

—

Perforation of tympanic membrane

394

1.53

2.56

1.3

—

nmol/l

—

Vitamin B12 deficiency anaemia

402

1.52

2.55

1.3

—

nmol/l

—

Diabetic retinopathy, excluding more controls

185

816

1.28

2.55

1.3

1.4

—

nmol/l

—

Malignant neoplasm of breast, HER-positive

153

1940

0.78

2.55

1.4

1.2

—

nmol/l

—

Nonpyogenic thrombosis of intracranial venous system

3.09

2.55

1.1

1.3

—

nmol/l

—

Acute epiglottitis

2.64

2.54

1.0

1.3

—

nmol/l

—

Hypothyroidism due to medicaments and other exogenous substances

3.09

2.54

1.4

1.5

—

nmol/l

—

Acute lymphadenitis

223

1.71

2.54

1.2

1.3

—

nmol/l

—

Sequelae of injuries of neck and trunk

101

2.10

2.54

1.2

1.3

—

nmol/l

—

Ulcer of oesophagus

208

1.74

2.54

1.4

1.2

—

nmol/l

—

Visual field defects

300

1.61

2.53

1.2

1.3

—

nmol/l

—

Other disorders of Eustachian tube

108

2.06

2.53

1.1

1.4

—

Methotrexate

642

1.41

2.52

1.1

1.3

—

nmol/l

—

Allergic urticaria

316

1.59

2.52

1.1

1.3

—

nmol/l

—

Spinal instabilities

2.18

2.52

1.2

—

nmol/l

—

Common variable immunodeficiency

3.56

2.51

1.2

1.4

—

nmol/l

—

Herpesviral [herpes simplex] infections

469

1.48

2.50

1.4

1.3

—

nmol/l

—

2.13

2.50

1.5

1.4

—

nmol/l

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

142

658

1.32

2.50

1.3

—

nmol/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.13

2.49

1.5

1.2

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

585

1.43

2.49

1.3

—

nmol/l

—

Volvulus

2.34

2.49

2.1

1.2

—

nmol/l

—

Lesion of femoral nerve

3.89

2.48

1.0

1.4

—

Atrophic disorders of skin

678

1.39

2.48

1.2

1.3

—

nmol/l

—

Parkinson's disease, excluding more controls

410

1.50

2.48

1.5

1.3

—

nmol/l

—

Medial epicondylitis

144

1.89

2.47

1.0

1.4

—

nmol/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.71

2.46

1.4

1.3

—

nmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.59

2.46

1.1

1.2

—

nmol/l

—

Other/unspecified synovitis and tenosynovitis

471

1.47

2.45

1.2

1.3

—

nmol/l

—

Aortic valve malfunction, age under 60 years

382

1.53

2.45

1.4

1.3

—

nmol/l

—

Central retinal artery occlusion

2.58

2.45

1.4

1.3

—

nmol/l

—

Chalazion

455

1.48

2.45

1.1

1.3

—

nmol/l

—

Idiopathic gout

295

1.60

2.44

1.2

1.3

—

nmol/l

—

Other hearing loss

141

1065

1.30

2.44

1.3

—

nmol/l

—

Other or unspecified common variable immunodeficiency

5.20

2.43

1.3

—

Other congenital malformations of nervous system

2.99

2.43

1.0

1.4

—

nmol/l

—

Haemangioma and lymphangioma, any site

359

1.54

2.43

1.4

1.3

—

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

375

1.53

2.43

1.1

1.3

—

nmol/l

—

Other disorders of the genitourinary system

597

1.41

2.42

1.2

1.3

—

nmol/l

—

Mild or no visual impairment, binocular

5.14

2.42

1.2

—

222

0.40

2.42

1.3

—

nmol/l

—

Other symptoms and signs involving general sensations and perceptions

110

2.02

2.41

1.2

1.3

—

nmol/l

—

Primary open-angle glaucoma

174

1341

1.27

2.41

1.3

—

nmol/l

—

Neovascular glaucoma

117

1.98

2.41

1.8

1.3

—

nmol/l

—

Other infectious diseases

273

1.62

2.40

1.3

—

nmol/l

—

Paraplegia, diplegia of upper limbs

2.37

2.40

1.3

—

nmol/l

—

Hemiplegia

182

1.77

2.40

1.2

1.3

—

nmol/l

—

Redundant prepuce, phimosis and paraphimosis

102

747

1.36

2.39

1.2

1.3

—

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

2.23

2.39

1.2

1.3

—

nmol/l

—

Intercostal neuropathy

3.71

2.38

1.1

1.4

—

Benign neoplasm: Larynx

2.08

2.38

1.8

1.3

—

nmol/l

—

Other and unspecified local infections of skin and subcutaneous tissue

353

1.54

2.37

1.4

1.3

—

nmol/l

—

Other obstructive and reflux uropathy

125

1.93

2.36

1.6

1.2

—

nmol/l

—

Malignant neoplasm of digestive organs

201

1596

1.24

2.35

1.4

1.3

—

nmol/l

—

Use of donepezil

615

0.62

2.35

1.2

1.3

—

nmol/l

—

Simple and mucopurulent chronic bronchitis

118

1.96

2.35

1.3

—

nmol/l

—

Psoriatic arthropathies

443

1.47

2.35

1.2

1.3

—

nmol/l

—

Primary open-angle glaucoma, strict

143

1106

1.29

2.35

1.3

—

nmol/l

—

Sequelae of injuries of head

176

1.77

2.34

1.2

1.3

—

nmol/l

—

Asthma and opportunity respiratory infection

147

1.85

2.33

1.5

1.2

—

nmol/l

—

Other and unspecified disorders of pigmentation

3.29

2.33

1.4

—

Cicatricial alopecia [scarring hair loss]

3.29

2.33

1.4

1.3

—

nmol/l

—

Ehlers-Danlos syndrome

2.91

2.32

1.1

—

nmol/l

—

Left bundle-branch block

237

1.65

2.32

1.3

—

nmol/l

—

Use of antiglaucoma preparations and miotics

268

1.61

2.32

1.3

—

nmol/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

119

1.95

2.31

1.3

1.4

—

nmol/l

—

Benign neoplasm: Ascending colon

519

1.43

2.31

1.6

1.3

—

nmol/l

—

Hereditary hypogammaglobulinemia

4.78

2.30

1.0

1.1

—

nmol/l

—

L02BA Anti-estrogens

851

0.68

2.30

1.5

1.3

—

nmol/l

—

Somnolence

2.72

2.29

1.7

1.3

—

nmol/l

—

Acute generalized exanthematous pustulosis

148

1.84

2.29

1.1

1.2

—

nmol/l

—

Retinal vascular occlusion

413

1.48

2.28

1.2

1.3

—

nmol/l

—

Myotonic disorders

3.55

2.28

1.0

1.4

—

nmol/l

—

Other arterial embolism and thrombosis

2.24

2.28

1.2

—

nmol/l

—

Delayed puberty

4.68

2.28

1.2

—

nmol/l

—

Vascular syndromes of brain in cerebrovascular disorders

141

1.86

2.28

1.2

1.3

—

nmol/l

—

Use of galantamine

185

0.38

2.28

1.6

1.2

—

nmol/l

—

Explicit fungal Sepsis

3.98

2.27

1.9

1.4

—

nmol/l

—

Unspecified renal colic

3.98

2.27

1.3

1.6

—

nmol/l

—

Benign neoplasm: Larynx

2.04

2.27

1.8

1.3

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

106

2.00

2.26

1.1

1.3

—

nmol/l

—

Sudden idiopathic hearing loss

382

1.50

2.25

1.3

—

nmol/l

—

Hallux valgus (acquired)

214

1260

1.23

2.25

1.2

1.3

—

nmol/l

—

Ulcer of vagina/vulva

2.12

2.24

1.2

—

nmol/l

—

Bursitis of shoulder

2.11

2.24

1.8

1.2

—

Psoas tendinitis

5.69

2.23

1.0

—

Congenital malformations of the nervous system

2.21

2.22

1.3

—

nmol/l

—

Monoplegia

2.44

2.21

1.2

1.3

—

nmol/l

—

Amputation of ankle bones

2.43

2.20

1.1

1.3

—

nmol/l

—

Parkinson's disease, strict definition, excluding more controls

368

1.50

2.20

1.5

1.3

—

nmol/l

—

Other local infections of skin and subcutaneous tissue

384

1.49

2.20

1.4

1.3

—

nmol/l

—

Pustular psoriasis

195

1.71

2.20

1.2

1.3

—

nmol/l

—

Wide developmental disorders, excluding more controls

2.26

2.19

1.1

1.4

—

nmol/l

—

Sarcoidosis

592

1.39

2.19

1.2

1.3

—

nmol/l

—

Abnormal findings on examination of urine, without diagnosis

143

1.83

2.19

1.7

1.3

—

nmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

2.65

2.19

1.3

1.5

—

nmol/l

—

Disorders of puberty

3.36

2.18

1.1

1.2

—

nmol/l

—

Presbyopia

257

1.61

2.18

1.5

1.4

—

nmol/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

3.78

2.17

1.0

1.8

—

Retinal vascular disorders

418

1.47

2.17

1.2

1.3

—

nmol/l

—

Glaucoma secondary to other eye disorders

122

1.90

2.16

1.8

1.3

—

nmol/l

—

Other cataract

258

1665

1.20

2.16

1.3

—

nmol/l

—

Other conjunctival vascular disorders and cysts

2.18

2.15

1.2

1.1

—

nmol/l

—

Speech and linguistic disorders, excluding more controls

213

1.64

2.15

1.3

—

nmol/l

—

5-aminosalicylic acid

125

965

1.30

2.15

1.1

1.3

—

nmol/l

—

Myeloproliferative diseases (CML excluded)

290

1.56

2.14

1.2

—

nmol/l

—

Chronic tubulo-interstitial nephritis

137

1.84

2.14

1.1

1.2

—

nmol/l

—

Residual foreign body in soft tissue

159

1.77

2.14

1.3

—

nmol/l

—

Burn and corrosion confined to eye and adnexa

2.12

2.13

1.2

1.3

—

nmol/l

—

Open wound of forearm

314

1.54

2.13

1.3

—

nmol/l

—

Other inflammatory liver diseases

243

1.61

2.13

1.2

1.3

—

nmol/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.39

2.13

1.2

—

nmol/l

—

Melanoma in situ of other and unspecified parts of face

2.75

2.12

1.0

1.1

—

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

404

1.47

2.11

1.2

1.3

—

nmol/l

—

Haemangioma, any site

339

1.51

2.11

1.4

1.2

—

nmol/l

—

Malignant neoplasm of head and neck

267

1.58

2.11

1.6

1.3

—

nmol/l

—

Other, unspecified and serous retinal detachments

2.02

2.11

1.9

1.3

—

nmol/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.27

2.11

1.0

1.5

—

Other and unspecified vascular occlusions

315

1.53

2.11

1.2

1.3

—

nmol/l

—

Paralytic ileus

102

1.97

2.11

1.5

1.4

—

nmol/l

—

Iliotibial band syndrome

3.24

2.10

1.3

1.7

—

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

580

1.38

2.10

1.4

1.3

—

nmol/l

—

Biomechanical lesions, not elsewhere classified

175

1.73

2.10

1.1

1.3

—

nmol/l

—

Other and unspecified cicatricial alopecia

5.24

2.10

1.6

1.1

—

Polyarthritis, unspecified

138

1.83

2.10

1.2

1.4

—

nmol/l

—

Contusion of toe(s) without damage to nail

2.15

2.09

1.6

1.3

—

nmol/l

—

Diagnoses used for exclusion with ILD

142

1119

1.27

2.09

1.3

—

nmol/l

—

Other specified/unspecified hearing loss

276

1.57

2.08

1.1

1.3

—

nmol/l

—

Bronchitis, not specified as acute or chronic

316

1.53

2.08

1.5

1.3

—

nmol/l

—

Psoriatic arthropathies, ICD10

456

1.43

2.06

1.2

1.3

—

nmol/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

161

1.75

2.06

1.3

—

Sacrococcygeal disorders, not elsewhere classified

1.99

2.06

1.2

1.3

—

nmol/l

—

Orchitis and epididymitis

277

1.56

2.05

1.2

1.3

—

nmol/l

—

Specific development disorders of scholastic skills

123

1.86

2.05

1.3

1.2

—

nmol/l

—

Other diseases of peritoneum

169

1.73

2.04

1.3

—

nmol/l

—

Endometriosis of rectovaginal septum and vagina

350

1.49

2.04

1.1

1.2

—

nmol/l

—

Intussusception

2.13

2.03

1.1

1.2

—

SLE (Finngen)

125

1.85

2.03

1.4

1.3

—

nmol/l

—

Acute bronchiolitis

138

1.77

2.03

1.1

1.2

—

nmol/l

—

Secondary parkinsonism, excluding more controls

2.42

2.03

1.3

—

Assault by bodily force

294

1.54

2.03

1.1

1.3

—

nmol/l

—

Arthropathy in Crohn disease

3.12

2.02

1.1

1.3

—

nmol/l

—

Vertigo of central origin

2.53

2.02

1.0

1.3

—

nmol/l

—

Superficial injury of neck

2.24

2.02

1.1

1.4

—

nmol/l

—

Disorders of optic nerve and visual pathways

351

1.49

2.01

1.2

1.3

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

239

1.60

2.01

1.3

1.2

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

239

1.60

2.01

1.3

—

nmol/l

—

Other diseases of spinal cord

1.98

2.01

1.3

1.2

—

nmol/l

—

Cardiomyopathies, Primary/intrinsic

426

1.44

1.99

1.4

1.3

—

nmol/l

—

Other acquired deformities of musculoskeletal system and connective tissue

178

1.70

1.99

1.0

1.3

—

nmol/l

—

Benign neoplasm of ovary

119

924

1.29

1.99

1.3

—

nmol/l

—

Alcohol dependence

148

1180

1.26

1.99

1.2

1.3

—

nmol/l

—

Arthropathic psoriasis

468

1.42

1.99

1.3

—

nmol/l

—

Unspecified privation

418

1.44

1.99

1.2

1.3

—

nmol/l

—

Myeloproliferative diseases

328

1.50

1.98

1.2

1.3

—

nmol/l

—

Pneumothorax

217

1.62

1.97

1.4

1.3

—

nmol/l

—

Oral leukoplakia and related diseases

202

1.64

1.96

1.2

—

nmol/l

—

Other and unspecified coagulation defects

179

1.69

1.95

1.1

1.3

—

nmol/l

—

Wilms' tumor

3.82

1.95

2.0

1.6

—

nmol/l

—

Flatulence and related conditions

3.00

1.94

1.8

1.1

—

nmol/l

—

Benign neoplasm: Short bones of lower limb

2.77

1.94

1.1

1.3

—

nmol/l

—

Calcaneal spur

2.48

1.94

1.4

1.3

—

nmol/l

—

Hypertrophy of (infrapatellar) fat pad

2.77

1.94

1.7

1.4

—

Asymmetry of jaw

2.47

1.94

1.6

1.3

—

nmol/l

—

Failure and rejection of transplanted organs and tissues

2.60

1.93

1.3

1.4

—

nmol/l

—

Brain meningioma

203

1.64

1.93

1.2

1.3

—

nmol/l

—

Other benign neoplasms of connective and other soft tissue

388

1.45

1.92

1.1

1.3

—

nmol/l

—

Pregnancy examination and test

439

1.34

1.92

1.2

—

nmol/l

—

Paranoid personality disorder

2.26

1.91

1.2

1.3

—

nmol/l

—

Open wound of shoulder and upper arm

2.26

1.91

1.8

1.4

—

nmol/l

—

Systemic sclerosis (FG)

2.02

1.91

1.4

1.2

—

nmol/l

—

Transplanted organ and tissue status

372

1.46

1.91

1.4

1.3

—

nmol/l

—

Right bundle-branch block

1.93

1.90

1.2

—

nmol/l

—

Other congenital malformations of face and neck

1.97

1.90

1.2

1.3

—

nmol/l

—

Cholesteatoma of external ear

3.24

1.89

1.1

1.5

—

Other psoriatic arthropathies

448

1.41

1.89

1.3

—

nmol/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

136

1.78

1.88

1.5

1.2

—

nmol/l

—

Fracture of neck

189

1.65

1.87

1.1

1.3

—

nmol/l

—

Disorders of brain, other and unspecified

2.90

1.87

1.1

1.3

—

nmol/l

—

Other specified disorders of external ear

107

1.88

1.86

1.2

1.4

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

333

1.48

1.86

1.4

1.3

—

nmol/l

—

Disorder of thyroid, unspecified

2.43

1.86

1.3

—

nmol/l

—

Melanoma in situ

129

1.80

1.86

1.2

—

nmol/l

—

Bell's palsy

466

1.40

1.86

1.2

1.3

—

nmol/l

—

Loose body in joint

2.04

1.86

1.1

1.4

—

nmol/l

—

Benign neoplasm of eye and adnexa

391

1.44

1.86

1.4

1.3

—

nmol/l

—

All dysplastic lesions of the vulva

182

1.66

1.85

1.1

1.3

—

nmol/l

—

Superficial injuries involving multiple body regions

1.99

1.85

1.1

1.2

—

nmol/l

—

Other specified disorders of muscle

1.95

1.85

1.3

—

nmol/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

245

1.56

1.85

1.2

1.3

—

nmol/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

4.29

1.84

2.8

1.4

—

nmol/l

—

Precocious central puberty

4.23

1.83

3.0

1.3

—

nmol/l

—

Haemangioma and lymphangioma, any site

384

1.44

1.83

1.4

1.3

—

nmol/l

—

Otitis media, unspecified

368

1.43

1.82

1.2

1.3

—

nmol/l

—

Lesion of plantar nerve

278

1.52

1.82

1.3

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

335

1.47

1.82

1.4

1.3

—

nmol/l

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

343

1.46

1.81

1.5

1.3

—

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

262

1.53

1.81

1.0

1.3

—

nmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum

3.10

1.81

2.7

1.2

—

nmol/l

—

Benign neoplasm: Short bones of lower limb

2.61

1.81

1.1

1.4

—

nmol/l

—

L02BG Aromatase inhibitors

131

1635

0.80

1.81

1.3

—

nmol/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

158

1.69

1.80

1.1

1.2

—

nmol/l

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.80

1.80

1.1

1.2

—

nmol/l

—

Premenstrual syndrome

2.79

1.80

1.3

1.2

—

nmol/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

215

1.59

1.80

1.2

—

nmol/l

—

Nontoxic diffuse goitre

116

1.82

1.79

1.1

1.2

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.38

1.79

1.1

1.4

—

nmol/l

—

Outcome of delivery

475

0.70

1.79

1.2

1.3

—

nmol/l

—

Other disorders of thyroid

2.37

1.79

1.3

—

nmol/l

—

Charcot foot

2.36

1.78

1.0

1.3

—

nmol/l

—

Injuries involving multiple body regions

131

1.77

1.78

1.1

1.3

—

nmol/l

—

Other bursopathies

539

1.36

1.77

1.2

1.3

—

nmol/l

—

Spermatocele

208

1.59

1.76

1.4

1.3

—

nmol/l

—

Other other unspecified disorders of the circulatory system

124

1.79

1.76

1.3

1.2

—

nmol/l

—

Other disorders of binocular vision

2.47

1.76

1.3

—

nmol/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.91

1.76

1.1

1.3

—

nmol/l

—

Haemangioma, any site

354

1.45

1.76

1.4

1.3

—

nmol/l

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

138

1073

1.25

1.76

1.2

1.3

—

nmol/l

—

Lichen planus

574

1.35

1.76

1.3

—

nmol/l

—

L04AC Interleukin inhibitors

185

1.63

1.75

1.1

1.4

—

nmol/l

—

Burns and corrosions confined to eye and internal organs

1.95

1.75

1.2

1.3

—

nmol/l

—

Dissection of aorta

1.99

1.75

1.4

1.3

—

nmol/l

—

Lifestyle-related condition

2.53

1.75

2.0

1.2

—

Attention to artificial openings

117

1.81

1.74

1.1

1.4

—

nmol/l

—

Abscess of anal and rectal regions

297

1.49

1.74

1.3

—

nmol/l

—

Total colectomy operation

147

1.71

1.74

1.8

1.3

—

nmol/l

—

Total colectomy

147

1.71

1.74

1.8

1.3

—

nmol/l

—

Blindness, monocular

2.71

1.73

1.3

1.4

—

Gastrojejunal ulcer

2.70

1.73

1.0

1.2

—

nmol/l

—

Disturbances of smell and taste

155

1.69

1.73

1.2

—

nmol/l

—

Other sideroblastic anaemias

3.95

1.73

1.0

1.7

—

nmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.16

1.72

1.2

1.3

—

nmol/l

—

Ptosis of eyelid

431

1.40

1.72

1.2

1.3

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.33

1.72

1.1

1.3

—

nmol/l

—

Flat foot [pes planus] (acquired)

423

1.40

1.71

1.4

1.3

—

nmol/l

—

Senility

3.86

1.71

1.2

1.3

—

nmol/l

—

Sequelae of injuries of lower limb

390

1.42

1.70

1.4

1.3

—

nmol/l

—

Biological medicines for asthma

2.41

1.68

1.2

1.3

—

nmol/l

—

Open wound of thorax

2.41

1.68

1.2

1.5

—

nmol/l

—

Other vitreous opacities

126

1.76

1.68

1.1

1.2

—

nmol/l

—

Use of rivastigmine

418

0.62

1.68

1.2

1.3

—

nmol/l

—

Pulmonary oedema

2.40

1.68

1.4

1.1

—

nmol/l

—

Urethral stricture

164

1.65

1.68

1.4

—

nmol/l

—

Malignant neoplasm of corpus uteri

383

1.42

1.68

1.2

—

nmol/l

—

Abnormal reflex

3.23

1.67

1.2

1.1

—

Mastocytosis

3.23

1.67

1.2

1.5

—

nmol/l

—

Wilms' tumor, excluding all cancers (controls excluding all cancers)

3.22

1.67

2.0

1.5

—

nmol/l

—

Other rupture of muscle

3.21

1.67

1.7

1.9

—

nmol/l

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

2.62

1.67

1.1

1.4

—

Diseases of spleen

2.12

1.66

1.6

1.3

—

nmol/l

—

Dermatitis herpetiformis

2.12

1.66

1.4

1.3

—

nmol/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

2.12

1.66

2.2

1.3

—

nmol/l

—

Background retinopathy and retinal vascular changes

2.12

1.66

1.7

1.3

—

nmol/l

—

Aphakia

2.60

1.66

1.3

1.2

—

nmol/l

—

Cholangitis (primary sclerosing, PSC)

188

1.60

1.66

1.1

1.3

—

nmol/l

—

Pseudomembranous colitis

2.84

1.66

1.4

—

nmol/l

—

6-mercaptopurine

1.90

1.65

1.2

1.4

—

nmol/l

—

Other and unspecified paralytic syndromes

2.27

1.64

1.1

1.3

—

nmol/l

—

Discitis, unspecified

2.27

1.64

1.0

1.3

—

nmol/l

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

461

1.37

1.64

1.2

—

nmol/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

105

1.82

1.63

1.2

1.3

—

nmol/l

—

Intermittent heterotropia

197

1.58

1.62

1.5

1.2

—

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

428

1.38

1.62

1.2

1.3

—

nmol/l

—

Melanoma in situ of other and unspecified parts of face

2.36

1.61

1.0

1.2

—

nmol/l

—

Enterocolitis due to Clostridium difficile

386

1.40

1.61

1.2

1.3

—

nmol/l

—

Adalimumab

361

1.42

1.61

1.1

1.3

—

nmol/l

—

Benign neoplasm: Long bones of lower limb

113

1.78

1.61

1.4

1.3

—

Achalasia of cardia

2.35

1.61

1.7

1.1

—

Previous suicide attempt

2.53

1.60

1.0

1.6

—

nmol/l

—

Benign neoplasm: Oesophagus

2.53

1.60

1.1

1.3

—

nmol/l

—

Scar conditions and fibrosis of skin

151

1.67

1.60

1.2

—

nmol/l

—

Myocardial infarction, unclassifiable

667

1.29

1.60

1.4

1.3

—

nmol/l

—

Myositis

1.92

1.60

1.1

1.3

—

nmol/l

—

Other and unspecified vasculitis limited to skin

1.97

1.60

1.5

1.2

—

nmol/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.02

1.59

1.2

—

nmol/l

—

Melanoma in situ

136

1.70

1.59

1.2

—

nmol/l

—

Other and unspecified primary disorders of muscles

2.74

1.59

1.1

1.2

—

nmol/l

—

Acquired stenosis of external ear canal

2.73

1.59

1.3

1.4

—

nmol/l

—

Other disorders starting during childhood or adolescence

135

1.70

1.58

1.0

1.2

—

nmol/l

—

HSIL lesion of the vagina

2.23

1.58

1.1

1.2

—

Contact with nonpowered hand tool

144

1.68

1.58

1.3

1.4

—

nmol/l

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

2.22

1.57

2.4

1.2

—

nmol/l

—

Golimumab

129

1.72

1.57

1.2

1.3

—

nmol/l

—

Convalescence

207

1.55

1.57

1.1

1.3

—

nmol/l

—

Melanocytic naevi, other sites/unspecified

305

1.45

1.56

1.2

1.3

—

nmol/l

—

Lesion of lateral popliteal nerve

160

1.63

1.56

1.4

—

nmol/l

—

Haemorrhagic disorder due to circulating anticoagulants

2.45

1.54

1.0

1.2

—

nmol/l

—

Wide developmental disorders

1.93

1.54

1.1

1.2

—

nmol/l

—

Osteonecrosis due to drugs

2.31

1.54

1.3

1.4

—

nmol/l

—

Crushing injury of wrist and hand

2.30

1.54

1.0

1.4

—

nmol/l

—

Complications associated with artificial fertilization

2.29

1.53

2.3

1.1

—

nmol/l

—

Other and unspecified diseases of spleen

3.41

1.53

1.4

1.6

—

nmol/l

—

Benign neoplasm: Other parts of oropharynx

2.63

1.52

2.0

1.4

—

nmol/l

—

Benign neoplasm: Rectosigmoid junction

138

1.68

1.52

1.2

—

nmol/l

—

Melanocytic naevi, other sites/unspecified

307

1.44

1.52

1.2

—

nmol/l

—

Right side

2.92

1.52

1.2

1.4

—

Inflammatory diseases of the central nervous system

307

1.44

1.51

1.2

1.3

—

nmol/l

—

Osteonecrosis

209

1.54

1.51

1.5

1.3

—

nmol/l

—

Other ulcerative colitis

209

1.54

1.51

1.1

1.3

—

nmol/l

—

Exposure to other and unspecified man-made environmental factors

2.18

1.51

1.0

1.4

—

nmol/l

—

Other congenital malformations of limb(s)

2.89

1.51

3.8

1.2

—

nmol/l

—

Habit and impulse disorders

2.18

1.51

1.5

—

nmol/l

—

Benign neoplasm: Duodenum

1.88

1.51

1.3

1.2

—

nmol/l

—

Benign neoplasm: Duodenum

1.88

1.51

1.3

1.2

—

nmol/l

—

Disorder of the sleep-wake schedule

2.09

1.50

1.3

1.4

—

nmol/l

—

Generalized skin eruption due to drugs and medicaments

131

1.69

1.50

1.1

1.2

—

nmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.02

1.49

1.2

1.3

—

nmol/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

1.96

1.49

2.1

1.3

—

nmol/l

—

Benign neoplasm: Long bones of lower limb

116

1.74

1.49

1.4

1.2

—

Other prurigo

2.25

1.47

1.0

1.4

—

nmol/l

—

Other disorders of male genital organs

109

1.75

1.47

1.5

1.4

—

nmol/l

—

Other articular cartilage disorders

1.85

1.46

1.1

1.4

—

nmol/l

—

Injury of intra-abdominal organs

1.85

1.46

1.1

1.3

—

nmol/l

—

Fall on and from ladder

268

1.46

1.2

1.3

—

nmol/l

—

Other specified and unspecified disorders of eyelid

2.39

1.46

1.2

1.3

—

nmol/l

—

Personal history of risk-factors, not elsewhere classified

2.39

1.46

1.0

1.5

—

nmol/l

—

Benign neoplasm: Other parts of oropharynx

2.53

1.46

2.0

1.3

—

nmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.53

1.46

1.1

1.4

—

nmol/l

—

Benign neoplasm: Rectosigmoid junction

140

1.65

1.45

1.2

—

nmol/l

—

Abscess of Bartholin gland

102

1.78

1.45

1.1

1.2

—

nmol/l

—

Congenital deformities of feet

1.89

1.45

1.0

1.3

—

Vitreous haemorrhage

386

1.38

1.45

1.3

—

nmol/l

—

Necrotizing fasciitis

3.19

1.45

1.6

1.5

—

nmol/l

—

Disorders of phosphorus metabolism and phosphatases

3.19

1.45

1.2

1.6

—

Alcohol withdrawal state with delirium

244

1.48

1.45

1.4

1.3

—

nmol/l

—

Paralytic strabismus

244

1.48

1.45

1.3

1.2

—

nmol/l

—

Exclusion endpoint for clefts

2.13

1.44

1.3

1.4

—

nmol/l

—

Other and unspecified disorders of binocular movement

3.18

1.44

1.4

1.1

—

nmol/l

—

Acquired clawhand, clubhand, clawfoot and clubfoot

2.78

1.44

1.0

1.4

—

Prepatellar bursitis

148

1.63

1.44

1.2

1.3

—

nmol/l

—

Mental retardation, excluding more controls

1.80

1.44

1.2

1.3

—

nmol/l

—

Systemic lupus erythematosus, unspecified

125

1.69

1.44

1.5

1.3

—

nmol/l

—

Systemic sclerosis, icd10

1.81

1.44

1.4

1.2

—

nmol/l

—

Use of cabergoline

2.33

1.43

1.1

1.4

—

nmol/l

—

Meralgia paraesthetica

110

1.74

1.43

1.2

—

nmol/l

—

Need for other prophylactic measures

204

1.53

1.43

1.3

—

nmol/l

—

Benign neoplasm of eye and adnexa

413

1.36

1.42

1.4

1.2

—

nmol/l

—

Inflammatory disease of cervix uteri

295

1.43

1.42

1.3

—

nmol/l

—

Other benign neoplasms of uterus

229

1.49

1.42

1.2

—

nmol/l

—

Stomatitis and related lesions

295

1.43

1.41

1.6

1.2

—

nmol/l

—

Overexertion and strenuous or repetitive movements

405

1.36

1.41

1.3

—

nmol/l

—

Chondromalacia

103

1.76

1.41

1.1

1.3

—

nmol/l

—

Other and unspecified glaucoma

229

1.49

1.41

1.3

—

nmol/l

—

Carcinoma in situ of colon

2.28

1.41

1.1

1.4

—

nmol/l

—

Other specified/unspecified necrotizing vasculopathies

2.20

1.40

1.3

—

nmol/l

—

Toxic effect of other and unspecified substances

2.27

1.40

1.2

1.6

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.20

1.40

1.0

1.5

—

nmol/l

—

Cardiomyopathy (excluding other)

457

1.34

1.40

1.4

1.3

—

nmol/l

—

Disorders of puberty, all

2.27

1.40

1.1

1.4

—

nmol/l

—

Recurring oral aphthae, including avohilmo

579

1.30

1.40

1.3

—

nmol/l

—

Pleural plaque

254

1.46

1.40

1.5

1.3

—

nmol/l

—

Psoriasis (vulgaris), strict definition

111

1.72

1.39

1.1

1.3

—

nmol/l

—

Amiodarone users

355

1.39

1.4

1.2

—

nmol/l

—

Pyogenic arthritis

238

1.48

1.39

1.5

1.4

—

nmol/l

—

Other disorders of prostate

1.90

1.39

1.1

1.3

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.09

1.39

1.3

—

nmol/l

—

Other benign neoplasms of connective and other soft tissue

415

1.35

1.39

1.1

1.3

—

nmol/l

—

Ulcerative rectosigmoiditis

313

1.41

1.39

1.1

1.3

—

nmol/l

—

Injury of urinary and pelvic organs

1.96

1.39

1.3

—

nmol/l

—

Fistulae involving female genital tract

2.02

1.39

2.2

1.2

—

nmol/l

—

Other misadventures during surgical and medical care

2.02

1.38

1.3

—

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

222

1.49

1.38

1.3

—

nmol/l

—

Oligomenorrhoea

119

1.69

1.38

1.2

—

nmol/l

—

Benign neoplasm: Ill-defined sites within the digestive system

2.65

1.37

2.5

1.1

—

Other benign neoplasm of uterus: Cervix uteri

2.65

1.37

1.5

1.1

—

Injury of cranial nerves

2.65

1.37

3.2

1.6

—

nmol/l

—

Malignant neoplasm of tonsil

2.22

1.37

2.7

1.3

—

nmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

247

1.46

1.37

1.3

—

nmol/l

—

Other congenital malformations of peripheral vascular system

2.22

1.37

1.1

1.3

—

nmol/l

—

Disorders of parathyroid gland, other and/or unspecified

2.65

1.37

2.2

1.2

—

nmol/l

—

Artificial opening status

174

1.56

1.37

1.1

1.3

—

nmol/l

—

Other and unspecified neuropathies

3.00

1.37

1.2

1.5

—

Other benign neoplasms of uterus

231

1.48

1.37

1.2

1.3

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.98

1.36

1.0

1.5

—

Systemic sclerosis

1.77

1.35

1.4

1.2

—

nmol/l

—

Unspecified misadventure during surgical and medical care

199

1.52

1.35

1.6

1.3

—

nmol/l

—

Primary biliary cholangitis (PBC)

1.88

1.35

1.0

1.3

—

nmol/l

—

Vestibular neuronitis

349

1.38

1.34

1.2

1.3

—

nmol/l

—

Malignant melanoma of skin

452

1.33

1.34

1.2

1.3

—

nmol/l

—

Sequelae of other external causes

183

1.54

1.34

1.2

1.3

—

nmol/l

—

Personal history of allergy to drugs, medicaments and biological substances

2.17

1.34

1.1

1.3

—

nmol/l

—

Childhood asthma (age<16), excluding more controls

343

1.34

1.3

—

nmol/l

—

Disorders of iron metabolism

2.15

1.34

1.4

—

Other mental disorders due to brain damage and dysfunction and to physical disease

392

1.36

1.34

1.6

1.3

—

nmol/l

—

Coxarthrosis, primary

339

2619

1.12

1.34

1.3

—

nmol/l

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

308

1858

1.13

1.34

1.3

1.2

—

nmol/l

—

Symptoms and signs involving emotional state

1.79

1.33

1.1

1.4

—

nmol/l

—

Primary ovarian failure

2.05

1.33

1.2

—

nmol/l

—

Acute appendicitis, with complications

109

887

1.23

1.33

1.1

1.3

—

nmol/l

—

Childhood asthma (age<16)

344

1.34

1.32

1.3

—

nmol/l

—

Sequelae of injuries of upper limb

410

1.35

1.32

1.5

1.3

—

nmol/l

—

Lichen planus, including avohilmo

106

861

1.23

1.32

1.4

1.3

—

nmol/l

—

Bicipital tendinitis

168

1.56

1.31

1.1

1.3

—

nmol/l

—

Exposure to other and unspecified animate mechanical forces

1.75

1.31

1.1

1.3

—

nmol/l

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

168

1.55

1.31

1.4

1.3

—

nmol/l

—

Benign neoplasm: Ill-defined sites within the digestive system

2.54

1.31

2.5

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

603

1.28

1.31

1.2

1.3

—

nmol/l

—

Bullous keratopathy

2.53

1.31

2.5

1.3

—

nmol/l

—

Malignant immunoproliferative diseases

2.53

1.31

1.0

1.4

—

nmol/l

—

Hydrocele

351

1.37

1.30

1.3

—

nmol/l

—

Papillary adenocarcinoma of thyroid gland

209

1.49

1.30

1.2

1.3

—

nmol/l

—

Epiphora

1.86

1.30

1.1

1.3

—

Retinal detachments and breaks

190

1632

1.17

1.30

1.3

—

nmol/l

—

Other specified and unspecified strabismus

2.38

1.30

1.3

—

Ankylosing hyperostosis [Forestier]

2.38

1.29

1.0

1.1

—

nmol/l

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

129

1.63

1.29

1.4

1.2

—

nmol/l

—

Use of biperiden

206

0.53

1.29

1.5

1.4

—

nmol/l

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

2.83

1.29

1.4

1.3

—

nmol/l

—

Carcinoma in situ of breast

2.83

1.29

1.4

1.2

—

nmol/l

—

Injury of nerves and spinal cord at thorax level

2.83

1.29

1.2

1.5

—

Infarction of spleen

2.82

1.29

1.8

1.2

—

nmol/l

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

2.81

1.29

1.0

1.1

—

nmol/l

—

Melanocytic naevi of lower limb, including hip

153

1.58

1.29

1.2

1.3

—

nmol/l

—

Benign neoplasm: Choroid

226

1.47

1.29

1.3

1.2

—

nmol/l

—

Male infertility

153

1.58

1.29

1.3

1.4

—

nmol/l

—

Ankylosing spondylitis

318

1.39

1.29

1.3

—

nmol/l

—

Maltreatment syndromes

169

1.54

1.28

1.2

1.4

—

nmol/l

—

Superficial injury of hip and thigh

534

1.29

1.28

1.3

—

nmol/l

—

Recurrent dislocation and subluxation of joint

276

1.42

1.28

1.1

1.3

—

nmol/l

—

Other and unspecified disorders of psychological development

2.48

1.28

1.0

1.1

—

nmol/l

—

Benign neoplasm: Cranial nerves

1.73

1.27

1.8

1.2

—

nmol/l

—

Traumatic subarachnoid haemorrhage

1.79

1.27

1.4

1.3

—

nmol/l

—

Sequelae of other accidents

2.30

1.27

1.1

1.3

—

nmol/l

—

Benign neoplasm of thyroid gland

130

1.63

1.27

1.6

1.2

—

nmol/l

—

Other appendicitis

336

1.37

1.27

1.2

1.3

—

nmol/l

—

Bacterial, viral and other infectious agents

336

1.37

1.27

1.6

1.3

—

nmol/l

—

Contact with sharp glass

130

1.62

1.27

1.1

1.3

—

nmol/l

—

Systemic lupus erythematosus

146

1.59

1.26

1.4

1.3

—

nmol/l

—

Foreign body in alimentary tract

178

1.52

1.26

1.4

1.2

—

nmol/l

—

Melanocytic naevi of lower limb, including hip

154

1.57

1.26

1.2

1.3

—

nmol/l

—

Malignant melanoma

607

1.27

1.26

1.1

1.3

—

nmol/l

—

Seborrhoeic keratosis

124

1030

1.21

1.26

1.3

—

nmol/l

—

Vasculitis limited to skin, not elsewhere classified

1.75

1.25

1.5

1.2

—

nmol/l

—

Other benign neoplasm of uterus: Cervix uteri

2.44

1.25

1.5

1.4

—

Benign neoplasm: Pharynx, unspecified

2.43

1.25

1.0

1.4

—

nmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.42

1.25

1.2

1.4

—

Horner syndrome

2.24

1.25

1.8

1.3

—

Other and unspecified injuries of head

203

1.48

1.24

1.1

1.3

—

nmol/l

—

Malignant neoplasm of larynx

2.24

1.24

1.1

—

nmol/l

—

Myocardial infarction, with ST-elevation

590

1.27

1.24

1.2

1.3

—

nmol/l

—

Malignant neoplasm of other connective and soft tissue

1.87

1.24

1.0

1.3

—

nmol/l

—

Secondary right heart disease

123

1.63

1.24

1.3

1.2

—

nmol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

115

949

1.21

1.24

1.3

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

100

1.71

1.24

1.2

1.3

—

nmol/l

—

Postpartum haemorrhage due to retained placenta

504

0.71

1.23

1.2

—

nmol/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.98

1.22

1.2

1.3

—

nmol/l

—

Additional codes for the location of defect, injury or illness

204

1.48

1.22

1.2

1.3

—

nmol/l

—

Disorders of purine and pyrimidine metabolism

2.67

1.22

1.4

1.3

—

nmol/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.18

1.22

1.0

1.3

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.18

1.22

1.4

1.5

—

nmol/l

—

Other maltreatment syndromes

116

1.65

1.21

1.2

1.4

—

nmol/l

—

Fracture of lumbar spine and pelvis

105

860

1.22

1.21

1.2

1.3

—

nmol/l

—

Benign neoplasm of thyroid gland

132

1.60

1.21

1.6

1.2

—

nmol/l

—

Superficial injury of thorax

611

1.26

1.20

1.2

1.3

—

nmol/l

—

Inguinal hernia, bilateral

348

0.66

1.20

1.3

—

nmol/l

—

Deep endometriosis

453

1.31

1.19

1.1

1.2

—

nmol/l

—

Benign neoplasm: Pharynx, unspecified

2.34

1.19

1.0

1.7

—

nmol/l

—

Autoimmune hepatitis

2.34

1.19

1.3

1.2

—

Palindromic rheumatism

2.13

1.19

1.3

1.4

—

Carcinoma in situ of skin of ear and external auricular canal

2.32

1.19

1.3

1.2

—

nmol/l

—

Contusion of ankle

125

1.61

1.18

1.3

—

nmol/l

—

Short Achilles tendon (acquired)

1.71

1.18

1.1

1.2

—

SLE, strict definition

141

1.57

1.17

1.5

1.2

—

nmol/l

—

SLE, ICD10

141

1.57

1.17

1.5

1.2

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.95

1.17

1.3

—

nmol/l

—

Amyloidosis

1.94

1.17

1.2

1.4

—

nmol/l

—

Lesion of sciatic nerve

133

1.59

1.17

1.1

1.3

—

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

231

1.43

1.17

1.3

1.2

—

nmol/l

—

Synovial cyst of popliteal space [Baker]

273

1.40

1.17

1.3

—

nmol/l

—

Non-small cell lung cancer, adenocarcinoma

198

1.47

1.17

1.1

1.3

—

nmol/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

198

1.47

1.17

1.1

1.3

—

nmol/l

—

Event of undetermined intent

223

1.44

1.16

1.2

1.4

—

nmol/l

—

Behavioural disorders, excluding more controls

2.01

1.16

1.3

1.6

—

nmol/l

—

Other bursitis of knee

2.07

1.15

1.3

1.6

—

nmol/l

—

Other and unspecified vaccines and biological substances

2.53

1.15

1.2

—

Disorders of synovium and tendon in diseases classified elsewhere

1.82

1.15

1.0

1.3

—

LSIL lesion of the vulva

134

1.58

1.15

1.1

1.3

—

nmol/l

—

Other and unspecified disorders of skin and subcutaneous tissue

249

1.41

1.14

1.1

1.3

—

nmol/l

—

Herpesviral keratitis and keratoconjunctivitis

150

1.54

1.14

1.5

1.3

—

nmol/l

—

Other and unspecified follicular disorders

142

1.56

1.14

1.3

1.4

—

nmol/l

—

Ingrowing nail

199

1.46

1.14

1.2

1.3

—

nmol/l

—

Hypertrophic disorders of skin

224

1.43

1.14

1.4

1.3

—

nmol/l

—

Follow-up care involving plastic surgery

154

0.52

1.14

1.1

1.2

—

nmol/l

—

Seronegative rheumatoid arthritis

527

1.27

1.14

1.2

1.3

—

nmol/l

—

Anxious personality disorder

1.86

1.14

1.0

1.4

—

nmol/l

—

Other and unspecified mood [affective] disorders

241

1.42

1.13

1.1

1.3

—

nmol/l

—

Malignant neoplasm of prostate

167

904

1.17

1.13

1.3

—

nmol/l

—

Congenital malformations of heart and great arteries

476

1.28

1.13

1.5

1.3

—

nmol/l

—

Graves ophthalmopathy

103

1.66

1.13

1.1

1.3

—

nmol/l

—

Inguinal or femoral hernia, bilateral

355

0.67

1.13

1.3

—

nmol/l

—

therapeutic use

103

1.66

1.13

1.0

1.3

—

nmol/l

—

Abnormality of white blood cells, not elsewhere classified

2.37

1.13

1.3

1.2

—

Macular pucker

590

1.26

1.13

1.1

1.3

—

nmol/l

—

Exfoliative dermatitis

2.02

1.12

1.3

—

nmol/l

—

Oral leukoplakia

1.91

1.12

1.1

1.3

—

nmol/l

—

Exposure to other specified electric current

2.02

1.12

1.0

1.5

—

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

111

1.63

1.12

1.4

1.2

—

nmol/l

—

Endometriosis of intestine

2.01

1.12

1.0

1.1

—

Sequelae of tuberculosis

2.01

1.12

1.3

1.4

—

nmol/l

—

Unspecified abortion

233

0.60

1.12

1.1

1.3

—

Amyloidosis, other/unspecified

1.98

1.11

1.1

1.4

—

nmol/l

—

Other specified/unspecified deforming dorsopathies

1.97

1.11

1.1

1.5

—

nmol/l

—

Other pulmonary heart/vessel disease

135

1.56

1.11

1.3

1.2

—

nmol/l

—

Autism spe, excluding more controls

1.97

1.11

1.2

1.4

—

nmol/l

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

1.79

1.11

1.2

—

nmol/l

—

Open wound of neck

2.29

1.11

1.1

1.3

—

nmol/l

—

Ascites

234

1.42

1.10

1.5

1.3

—

nmol/l

—

Disorders of orbit

168

1.50

1.10

1.0

1.3

—

nmol/l

—

All dysplastic lesions of the vagina

104

1.65

1.10

1.1

1.3

—

nmol/l

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

201

1.45

1.10

1.1

1.3

—

nmol/l

—

Other and unspecified disorders of adult personality and behaviour

2.41

1.09

1.0

1.4

—

nmol/l

—

Other injuries of lower limb, level unspecified

2.40

1.09

1.4

1.1

—

nmol/l

—

Unspecified parasitic disease

2.40

1.09

1.0

1.1

—

nmol/l

—

Leukaemia of unspecified cell type

2.40

1.09

1.0

1.5

—

Leukaemia of unspecified cell type

2.40

1.09

1.0

1.4

—

Traction detachment of retina

2.40

1.09

1.6

1.5

—

Transient synovitis

2.40

1.09

1.0

1.5

—

Tuberculosis of other organs

1.83

1.09

1.9

1.2

—

nmol/l

—

Injury of nerves and spinal cord at neck level

1.83

1.09

1.2

—

nmol/l

—

Moderate visual impairment, binocular

1.74

1.09

1.2

—

nmol/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.97

1.09

1.0

1.5

—

nmol/l

—

Other benign neoplasm of uterus: Corpus uteri

2.22

1.09

1.0

1.3

—

nmol/l

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

2.21

1.08

1.0

1.4

—

Benign neoplasm of breast

576

1.25

1.08

1.3

1.2

—

nmol/l

—

Transient global amnesia

399

1.31

1.08

1.4

1.3

—

nmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

321

1.34

1.07

1.1

1.3

—

nmol/l

—

Lupus erythematosus

1.66

1.07

1.4

1.3

—

nmol/l

—

Female infertility, tubal origin

194

1.45

1.07

1.1

1.2

—

nmol/l

—

Congenital malformations of great arteries

1.94

1.06

1.0

1.5

—

nmol/l

—

Pneumonitis due to solids and liquids

236

1.40

1.06

1.7

1.3

—

nmol/l

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

2.14

1.06

1.9

1.2

—

nmol/l

—

Unspecified threat to breathing

2.14

1.06

1.1

1.4

—

nmol/l

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

2.14

1.06

1.1

1.4

—

nmol/l

—

Essential (haemorrhagic) thrombocythaemia

137

1.54

1.06

1.2

—

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

203

1.44

1.05

1.6

1.2

—

nmol/l

—

Hypertrophic scar

203

1.43

1.05

1.2

1.3

—

nmol/l

—

Heterophoria

305

1.35

1.05

1.4

1.3

—

nmol/l

—

Benign neoplasm: Choroid

237

1.40

1.04

1.3

1.2

—

nmol/l

—

Other condition

579

1.25

1.04

1.2

1.3

—

nmol/l

—

Carcinoma in situ of breast

2.31

1.04

1.4

1.2

—

nmol/l

—

Alzheimer’s disease (Atypical or mixed)

203

0.59

1.04

1.2

—

Malignant neoplasm of oropharynx

1.97

1.04

2.7

1.3

—

nmol/l

—

Hereditary retinal dystrophy

1.97

1.04

1.0

1.3

—

nmol/l

—

Use of rotigotine

2.08

1.03

1.4

1.2

—

nmol/l

—

Adult respiratory distress syndrome

2.08

1.03

1.3

—

nmol/l

—

Other specific arthropathies, wide

1.75

1.03

1.2

1.3

—

Cerebral atherosclerosis

2.07

1.03

1.3

1.4

—

nmol/l

—

Nail disorders

324

1.33

1.02

1.2

1.3

—

nmol/l

—

Pollen allergy

771

1.21

1.02

1.2

1.3

—

nmol/l

—

Laparoscopic left hemicolectomy

1.90

1.02

1.1

1.4

—

nmol/l

—

Personal history of certain other diseases

1.90

1.01

1.0

1.3

—

nmol/l

—

Chronic myeloproliferative disease

1.89

1.01

1.1

1.3

—

nmol/l

—

Other lack of coordination

1.89

1.01

1.0

1.5

—

nmol/l

—

Idiopathic thrombocytopenic purpura

1.66

1.01

1.7

1.3

—

nmol/l

—

Female infertility, associated with anovulation

256

1.37

1.00

1.6

1.2

—

nmol/l

—

Benign neoplasm: Skin of lower limb, including hip

1.63

1.00

1.2

1.3

—

nmol/l

—

Other and unspecified intracranial injuries

1.62

1.00

1.1

1.3

—

nmol/l

—

Muscle strain

1.62

1.00

1.1

1.4

—

nmol/l

—

Viral hepatitis

282

1.35

1.00

1.4

1.3

—

nmol/l

—

Injury of nerves at wrist and hand level

131

1.53

1.00

1.4

—

nmol/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

153

1430

0.87

0.99

1.4

1.2

—

nmol/l

—

Use of disulfiram, acamprosate or naltrexone

352

1.31

0.99

1.2

1.3

—

nmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

1.82

0.99

1.6

1.2

—

nmol/l

—

Habitual aborter

1.85

0.98

1.2

1.1

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.20

0.98

1.0

1.4

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

257

1.37

0.98

1.4

1.3

—

nmol/l

—

Liposarcoma

2.20

0.98

1.0

1.4

—

Recurrent and persistent haematuria

2.19

0.98

1.0

1.2

—

nmol/l

—

Synovial hypertrophy, not elsewhere classified

2.19

0.98

1.0

1.8

—

Dermatophytosis

521

1.25

0.98

1.4

1.3

—

nmol/l

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.98

0.0

1.6

—

malignant neoplasm of male genital organs

172

952

1.15

0.98

1.3

—

nmol/l

—

Gonococcal infection

140

1.51

0.98

1.3

—

nmol/l

—

Trichomoniasis

1.97

0.97

1.3

1.2

—

Benign neoplasm: other/unspecified salivary gland

1.64

0.97

1.3

1.2

—

nmol/l

—

Ovarian hyperstimulation (induction)

1.86

0.97

2.3

1.2

—

nmol/l

—

Pneumococcal septicemia

100

1.61

0.97

1.2

—

nmol/l

—

Benign neoplasm: Cranial nerves

108

1.58

0.97

1.8

1.3

—

nmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

258

1.36

0.97

1.3

—

nmol/l

—

Noise effects on inner ear

116

1.56

0.96

1.2

1.4

—

nmol/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.63

0.96

1.3

—

nmol/l

—

Motorcycle rider injured in other and unspecified transport accidents

207

1.41

0.96

1.1

1.3

—

nmol/l

—

Lichen sclerosus et atrophicus

469

1.26

0.96

1.2

1.3

—

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

267

1.35

0.96

1.4

1.2

—

nmol/l

—

Fourth [trochlear] nerve palsy

1.70

0.95

1.2

1.3

—

nmol/l

—

Juvenile arthritis (FINNGEN)

149

1.48

0.95

1.4

1.3

—

nmol/l

—

Carcinoma in situ of colon

1.78

0.95

1.1

1.3

—

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

1.78

0.95

1.3

—

Circumscribed brain atrophy

1.77

0.95

1.0

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

208

1.40

0.94

1.6

1.2

—

nmol/l

—

Erosion of teeth

1.79

0.94

1.0

1.1

—

nmol/l

—

Macular cyst

1.66

0.94

1.1

1.3

—

nmol/l

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

1.91

0.94

1.1

1.2

—

Unspecified event, undetermined intent

1.66

0.94

1.4

1.3

—

nmol/l

—

Dental caries 3 and operation codes, only avohilmo

209

928

1.13

0.94

1.3

—

nmol/l

—

Puerperal sepsis

696

1.21

0.94

1.2

1.3

—

nmol/l

—

Pneumonia derived septicemia

101

1.59

0.93

1.2

—

nmol/l

—

Open bite

158

1.46

0.93

1.9

1.3

—

nmol/l

—

Ulcerative proctitis

217

1.39

0.93

1.2

1.3

—

nmol/l

—

Wegener granulomatosis

1.74

0.92

1.3

—

nmol/l

—

Follicular lymphoma, hilmo

142

1.49

0.92

1.1

1.3

—

nmol/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

1.83

0.92

1.2

1.1

—

nmol/l

—

Injury of other and unspecified intrathoracic organs

209

1.39

0.92

1.5

1.3

—

nmol/l

—

Osteitis due to dental implant

2.18

0.92

1.0

1.4

—

Leiomyosarcoma

2.17

0.92

1.2

1.1

—

Contusion of other and unspecified parts of foot

167

1.44

0.92

1.2

1.3

—

nmol/l

—

Female infertility

173

937

1.14

0.92

1.2

—

nmol/l

—

Benign neoplasm of breast

590

1.22

0.91

1.3

—

nmol/l

—

Benign neoplasm: other/unspecified salivary gland

1.60

0.91

1.3

1.1

—

nmol/l

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

176

1.43

0.90

1.4

1.2

—

nmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

1.76

0.90

2.2

1.2

—

nmol/l

—

Other and unspecified iridocyclitis

151

1.46

0.90

1.2

1.3

—

nmol/l

—

Need for immunization against other single viral diseases

1.76

0.90

1.5

1.3

—

nmol/l

—

Other viral hepatitis

227

1.37

0.90

1.5

1.3

—

nmol/l

—

Other respiratory diseases principally affecting the interstitium

663

1.21

0.90

1.5

1.3

—

nmol/l

—

Focal brain injury

176

1.42

0.90

1.0

1.3

—

nmol/l

—

Conduct disorder

1.76

0.90

1.3

1.4

—

nmol/l

—

Injury of eye and orbit

600

1.22

0.90

1.2

1.3

—

nmol/l

—

Melanocytic naevi of lip

2.09

0.90

1.0

1.2

—

nmol/l

—

Other and unspecified psoriasis

236

1.36

0.89

1.5

1.3

—

nmol/l

—

Other and unspecified aplastic anaemias

2.08

0.89

1.0

1.2

—

nmol/l

—

Tic and related disorders

2.08

0.89

1.0

1.4

—

nmol/l

—

Carcinoma in situ of skin

262

1.34

0.89

1.2

1.3

—

nmol/l

—

Oral lichen ruber planus, hypothyreosis or thyroxin

1.71

0.89

1.2

—

nmol/l

—

Benign neoplasm of major salivary glands

376

1.28

0.89

1.2

1.3

—

nmol/l

—

Traumatic ischaemia of muscle

1.92

0.89

1.6

1.3

—

nmol/l

—

Guttate psoriasis

1.92

0.89

1.3

—

Foreign body or object entering through skin

211

1.38

0.88

1.5

1.3

—

nmol/l

—

Toxic effect of contact with venomous animals

152

1.45

0.88

1.0

1.3

—

nmol/l

—

Lesion of radial nerve

119

1.52

0.88

1.1

1.4

—

nmol/l

—

Certolizumab pegol

1.80

0.88

1.2

1.3

—

nmol/l

—

Cardiomyopathy, Hypertrophic obstructive

1.80

0.88

1.2

1.3

—

nmol/l

—

1.80

0.88

1.1

1.3

—

nmol/l

—

Unspecified urinary incontinence

377

1.28

0.88

1.2

1.3

—

nmol/l

—

Lung diseases due to external agents

475

1.24

0.88

1.5

1.3

—

nmol/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

157

0.60

0.88

1.3

—

Benign neoplasm: Skin of lower limb, including hip

103

1.56

0.87

1.2

1.3

—

nmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

237

1.35

0.87

1.2

1.3

—

nmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

237

1.35

0.87

1.2

1.3

—

nmol/l

—

Benign neoplasm: Oesophagus

1.88

0.87

1.1

1.3

—

nmol/l

—

Disorder of external ear, unspecified

103

1.56

0.87

1.1

1.3

—

nmol/l

—

Alopecia areata

1.59

0.87

1.1

1.3

—

nmol/l

—

Family history of other conditions

1.87

0.87

2.9

1.3

—

nmol/l

—

ILD-related respiratory insufficiency

1.59

0.87

2.3

1.2

—

nmol/l

—

Rheumatic fever incl heart disease

1.59

0.87

1.1

1.2

—

nmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.02

0.87

1.2

1.4

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

503

1.24

0.87

1.2

1.3

—

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

121

1045

1.16

0.86

1.4

1.3

—

nmol/l

—

Parapsoriasis

1.73

0.86

1.2

1.4

—

nmol/l

—

Dermatitis due to substances taken internally

212

1.37

0.86

1.2

1.3

—

nmol/l

—

Benign neoplasm: Tonsil

1.83

0.86

1.6

1.2

—

Benign neoplasm: Tonsil

1.83

0.86

1.6

1.2

—

Other acute skin changes due to ultraviolet radiation

120

1.51

0.85

1.2

—

nmol/l

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

145

1.45

0.85

1.0

1.3

—

nmol/l

—

Other melanin hyperpigmentation

1.64

0.85

1.5

1.3

—

nmol/l

—

Malignant neoplasm of stomach

145

1.45

0.85

1.5

1.3

—

nmol/l

—

Melanocytic naevi of lip

1.95

0.85

1.0

1.3

—

nmol/l

—

Malignant immunoproliferative diseases

1.95

0.85

1.0

1.4

—

nmol/l

—

Rare circulating lymphoid malignancy

1.63

0.84

1.6

1.3

—

nmol/l

—

Kyphosis

1.95

0.84

1.0

1.2

—

Measles

1.79

0.84

1.3

1.5

—

nmol/l

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

1.57

0.84

1.1

1.2

—

nmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

335

1.29

0.84

1.3

—

nmol/l

—

Pneumonia due to Streptococcus pneumoniae

137

1.47

0.84

1.5

1.3

—

nmol/l

—

Amputation

300

1.30

0.84

1.2

1.3

—

nmol/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

102

1.54

0.83

1.3

—

nmol/l

—

Open wound of ankle and foot

380

1.27

0.83

1.2

1.3

—

nmol/l

—

Other diseases of arteries and capillaries

318

1.29

0.83

1.2

1.3

—

nmol/l

—

Presbycusis

414

1.25

0.83

1.3

—

nmol/l

—

Respiratory disorders in diseases classified elsewhere

1.75

0.83

1.3

1.1

—

Persistent delusional disorders

301

1.30

0.82

1.1

1.3

—

nmol/l

—

Separation of retinal layers (serosa)

146

1.44

0.82

1.2

1.4

—

nmol/l

—

Scabies

146

1.44

0.82

1.1

1.4

—

nmol/l

—

Fibrosis and cirrhosis of liver

275

1.31

0.82

1.3

—

nmol/l

—

Contact with heat and hot substances

180

1.39

0.82

1.2

1.3

—

nmol/l

—

Other surgical follow-up care

105

1.53

0.82

1.1

1.3

—

nmol/l

—

Dependence on enabling machines and devices, not elsewhere classified

1.88

0.81

1.0

1.5

—

nmol/l

—

Other renal tubulo-interstitial diseases

1.61

0.81

1.1

1.3

—

nmol/l

—

Isolated proteinuria

1.58

0.81

1.1

1.3

—

nmol/l

—

Alcoholic liver disease

346

1.27

0.81

1.5

1.3

—

nmol/l

—

severe traumatic brain injury, does not include concussion

828

1.17

0.81

1.1

1.3

—

nmol/l

—

Lung cancer and mesothelioma

605

1.19

0.81

1.2

1.3

—

nmol/l

—

Acute and transient psychotic disorders

517

1.22

0.81

1.2

1.3

—

nmol/l

—

Unspecified visual impairment (binocular)

1.71

0.81

1.3

—

Organic, including symptomatic, mental disorders

206

1654

0.90

0.81

1.3

—

nmol/l

—

Pediculosis, acariasis and other infestations

198

1.37

0.80

1.1

1.4

—

nmol/l

—

Perichondritis of external ear

1.74

0.80

1.2

1.3

—

nmol/l

—

Malnutrition

1.73

0.80

2.0

1.3

—

nmol/l

—

Caught, crushed, jammed or pinched in or between objects

164

1.41

0.80

1.3

—

nmol/l

—

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.2

—

Personal history of medical treatment

0.00

0.79

0.0

1.5

—

Uterine polyps

455

1.23

0.79

1.1

1.2

—

nmol/l

—

Contact with venomous snakes and lizards

1.83

0.79

1.0

1.4

—

nmol/l

—

Tic disorders

1.83

0.79

1.0

1.3

—

nmol/l

—

Carcinoma in situ of skin

268

1.31

0.79

1.2

1.3

—

nmol/l

—

Microscopic polyangiitis

0.00

0.79

0.0

1.2

—

Polyarteritis nodosa and related conditions

1.68

0.79

1.4

1.3

—

nmol/l

—

Assault by blunt object

1.68

0.79

1.4

1.6

—

Complications following infusion, transfusion and therapeutic injection

1.68

0.79

1.1

1.2

—

Sexual dysfunction

1.68

0.79

1.0

1.4

—

nmol/l

—

Other diseases of biliary tract

321

1.28

0.79

1.2

1.3

—

nmol/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.68

0.79

1.6

1.5

—

nmol/l

—

Other juvenile arthritis

131

1.46

0.78

1.4

1.3

—

nmol/l

—

Crowding of teeth, including avohilmo

228

1.31

0.78

1.2

—

nmol/l

—

Contact with machinery

402

1.25

0.78

1.2

1.3

—

nmol/l

—

Bicuspidal aortic valve syndrome

123

1.47

0.77

1.1

1.3

—

nmol/l

—

Explicit bacterial Sepsis

322

1.28

0.77

1.1

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified intrathoracic organs

1.78

0.76

2.3

1.2

—

nmol/l

—

Vitiligo

1.78

0.76

1.8

1.2

—

Meningococcal infection

0.00

0.76

0.0

1.4

—

Contact with lifting and transmission devices, not elsewhere classified

1.71

0.76

1.1

1.3

—

nmol/l

—

Other interventions on the root canals of the tooth

1.71

0.76

1.2

1.4

—

nmol/l

—

Normotensive glaucoma

332

1.27

0.76

1.1

1.3

—

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

183

1.37

0.76

1.3

—

nmol/l

—

Benign neoplasm: Other/unspecified site

1.71

0.75

1.2

1.5

—

LeFortI or BSSRO operation

149

1.41

0.75

1.5

1.4

—

nmol/l

—

Complications of genitourinary prosthetic devices, implants and grafts

1.57

0.75

1.4

1.2

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.57

0.75

1.2

—

nmol/l

—

Malignant neoplasm, without specification of site

1.61

0.75

1.3

—

nmol/l

—

Malignant neoplasm of parotid gland

2.10

0.75

2.2

1.2

—

nmol/l

—

Dacryoadenitis

2.10

0.75

2.2

1.4

—

Sequelae of poliomyelitis

2.10

0.75

1.0

1.4

—

Optic atrophy

1.68

0.74

1.2

1.3

—

nmol/l

—

Divergent concomitant strabismus

301

0.73

0.74

1.1

1.3

—

nmol/l

—

Mental retardation

116

1.47

0.74

1.2

1.3

—

nmol/l

—

Other hammer toe(s) (acquired)

784

1.16

0.74

1.3

—

nmol/l

—

Failed attempted abortion

1.85

0.74

1.0

1.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

1.65

0.74

1.2

1.3

—

Benign neoplasm: Other/unspecified site

1.65

0.73

1.2

1.4

—

Routine general health check-up of defined subpopulation

1.64

0.73

1.1

—

Nummular dermatitis

316

1.27

0.73

1.3

—

nmol/l

—

Other benign neoplasm of uterus: Corpus uteri

1.82

0.73

1.0

1.3

—

nmol/l

—

Other congenital malformations of female genitalia

2.01

0.73

1.4

1.2

—

nmol/l

—

Suggestive for eosinophilic asthma

352

1.25

0.73

1.2

1.3

—

nmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.81

0.73

1.1

1.5

—

nmol/l

—

Panniculitis, unspecified

1.81

0.73

1.0

1.5

—

Cholesteatoma of middle ear

176

1.37

0.72

1.4

1.3

—

nmol/l

—

CR(E)ST syndrome

1.68

0.72

1.5

1.3

—

nmol/l

—

Nonischemic cardiomyopathy

185

1.36

0.72

1.5

1.3

—

nmol/l

—

Tuberculosis of other organs, strict

1.59

0.72

1.9

1.2

—

nmol/l

—

Postpartum hemorraghe, parous women as controls

103

1036

0.87

0.72

1.4

1.2

—

nmol/l

—

Postzoster neuralgia

1.76

0.71

1.1

1.3

—

nmol/l

—

Other demyelinating diseases of the central nervous system

134

1.42

0.71

1.4

1.3

—

nmol/l

—

Other and unspecified injuries of thorax

1.59

0.71

1.0

1.2

—

nmol/l

—

Cholera

194

0.67

0.71

1.2

1.3

—

nmol/l

—

Polymyositis

1.94

0.71

1.0

1.3

—

nmol/l

—

Open bite that required surgery (Lefort1 or BSSRO)

1.94

0.71

1.2

1.1

—

Other bursitis, not elsewhere classified

1.94

0.71

1.4

1.1

—

nmol/l

—

Colorectal cancer

108

943

1.15

0.70

1.3

—

nmol/l

—

Malignant neoplasm of ovary

217

0.69

0.70

1.1

1.2

—

nmol/l

—

Car occupant injured in noncollision transport accident

126

1.43

0.70

1.2

1.3

—

nmol/l

—

Migraine without aura, drug-induced

1.72

0.70

1.6

1.2

—

nmol/l

—

Late syphilis

1.72

0.70

1.1

1.2

—

nmol/l

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

496

1.20

0.70

1.1

1.3

—

nmol/l

—

Schizoid personality disorder

1.56

0.70

1.4

1.5

—

nmol/l

—

Mixed conductive and sensorineural hearing loss

472

1.21

0.70

1.3

—

nmol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

115

1010

1.14

0.69

1.3

—

nmol/l

—

Ectropion of eyelid

1.51

0.69

1.2

—

nmol/l

—

Corneal scars and opacities

1.54

0.69

1.3

1.2

—

nmol/l

—

Retinoschisis and retinal cysts

1.57

0.69

1.2

—

nmol/l

—

Post-traumatic wound infection, not elsewhere classified

1.57

0.68

1.2

1.3

—

nmol/l

—

Autism spe

1.65

0.68

1.2

1.3

—

nmol/l

—

Autism

1.65

0.68

1.2

—

nmol/l

—

Abscess of external ear

1.68

0.68

1.0

1.3

—

nmol/l

—

Dislocation of lens

1.86

0.68

1.2

1.1

—

Amputation of toe

213

1.32

0.68

1.3

1.2

—

nmol/l

—

Bullous disorders

187

1.34

0.68

1.3

1.2

—

nmol/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

713

1.17

0.68

1.3

—

nmol/l

—

Hepatocellular carcinoma

1.63

0.67

1.4

1.3

—

nmol/l

—

Mixed specific developmental disorders

1.63

0.67

1.3

1.2

—

nmol/l

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

1.80

0.66

1.6

1.3

—

Sequelae of infectious and parasitic diseases

285

1.27

0.66

1.1

1.3

—

nmol/l

—

Drug-induced obesity

1.80

0.66

1.0

1.2

—

Pterygium

1.52

0.66

1.2

1.3

—

nmol/l

—

!Aliquae complicationes praecoces traumatis

145

1.38

0.66

1.4

1.3

—

nmol/l

—

Early complications of trauma

145

1.38

0.66

1.4

1.3

—

nmol/l

—

Nystagmus and other irregular eye movements

1.60

0.65

1.1

1.3

—

nmol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.60

0.65

1.3

—

nmol/l

—

Other and unspecified injuries of shoulder and upper arm

103

1.46

0.65

1.1

1.3

—

nmol/l

—

Manic episode

103

1.46

0.65

1.3

—

nmol/l

—

Otosclerosis

331

1.24

0.65

1.6

1.3

—

nmol/l

—

Other and unspecified disease of Bartholin gland

120

1.42

0.64

1.2

—

nmol/l

—

Erythema nodosum

120

1.42

0.64

1.4

1.3

—

nmol/l

—

Malignant neoplasm of breast, HER-negative

100

1138

0.88

0.64

1.2

1.3

—

nmol/l

—

145

1.38

0.64

1.2

—

nmol/l

—

Degenerative macular diseases

477

1.20

0.64

1.1

1.3

—

nmol/l

—

Ankylosing spondylitis, strict definition

163

1.35

0.64

1.2

1.3

—

nmol/l

—

Other congenital malformations of circulatory system

1.48

0.64

1.4

1.2

—

nmol/l

—

Other bullous disorders

1.48

0.64

1.4

1.3

—

nmol/l

—

Gout due to impairment of renal function

1.73

0.64

1.2

1.4

—

Other bacterial agents as the cause of diseases classified to other chapters

1.73

0.64

1.0

1.4

—

Deep bite

353

1.22

0.64

1.3

—

nmol/l

—

Glaucoma, exfoliation

377

1.22

0.63

1.2

1.3

—

nmol/l

—

Other secondary coxarthrosis

129

1.40

0.63

1.7

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

1.53

0.62

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia, helper endpoint

1.53

0.62

1.3

—

nmol/l

—

Reactive arthropathies, FINNGEN

279

1.26

0.62

1.2

1.3

—

nmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

553

1.18

0.62

1.4

1.3

—

nmol/l

—

Cutis laxa senilis

1.68

0.61

1.0

1.2

—

Lymphoid leukaemia

173

1.33

0.61

1.5

1.3

—

nmol/l

—

Benign neoplasm: Tongue

1.46

0.61

1.0

1.2

—

nmol/l

—

Dronedarone medication

1.46

0.61

1.2

—

nmol/l

—

Anoxic brain damage

1.67

0.61

1.0

1.3

—

nmol/l

—

Toxic liver disease

1.61

0.61

1.1

1.2

—

nmol/l

—

Guillain-Barre syndrome

1.61

0.61

1.4

—

nmol/l

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

104

902

1.13

0.61

1.2

—

nmol/l

—

Other osteochondropathies

262

1.26

0.61

1.0

1.3

—

nmol/l

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.60

0.0

1.4

—

Benign neoplasm: Orbit, unspecified

0.00

0.60

0.0

1.5

—

Scarlet fever

0.00

0.60

0.0

1.4

—

Other (seronegative) rheumatoid arthritis, wide

100

881

1.14

0.60

1.2

1.3

—

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.58

0.60

1.1

1.2

—

nmol/l

—

Allergic colitis

1.57

0.60

1.3

—

nmol/l

—

Lung transplant status

0.00

0.60

0.0

1.5

—

Lung transplantation

0.00

0.60

0.0

1.5

—

Cleft lip and cleft lip and palate

0.00

0.60

0.0

1.5

—

Burns and corrosions

564

1.17

0.60

1.2

1.3

—

nmol/l

—

Malignant neoplasm of colon

564

1.17

0.60

1.4

1.3

—

nmol/l

—

Secondary parkinsonism+Parkinsonism in other disease

1.51

0.60

1.3

—

Astigmatism

209

1.29

0.60

1.0

1.3

—

nmol/l

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.59

0.0

1.7

—

Ductal carcinoma of pancreas

0.00

0.59

0.0

1.1

—

Foreign body on external eye

611

1.16

0.59

1.2

1.3

—

nmol/l

—

Non-small cell lung cancer

537

1.17

0.59

1.1

1.3

—

nmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

1.54

0.59

1.6

1.2

—

nmol/l

—

Other and unspecified injuries of wrist and hand

131

1.38

0.59

1.2

1.3

—

nmol/l

—

Von Willebrand disease

1.52

0.58

1.5

1.2

—

nmol/l

—

Short stature, not elsewhere classified

1.76

0.58

1.3

1.2

—

nmol/l

—

Impacted maxillary canine

0.00

0.58

0.0

1.4

—

Idiopathic pulmonary fibrosis

231

0.73

0.58

1.5

1.3

—

nmol/l

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

345

1.22

0.58

1.5

1.3

—

nmol/l

—

Alzheimer’s disease (Early onset)

115

0.61

0.57

1.3

1.1

—

nmol/l

—

Generalized epilepsy

149

1.35

0.57

1.2

1.3

—

nmol/l

—

Psoriasis vulgaris

838

1.14

0.57

1.3

—

nmol/l

—

Other meningitis

1.49

0.57

1.4

1.3

—

nmol/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.49

0.57

1.0

1.3

—

nmol/l

—

Other noninflammatory disorders of cervix uteri

220

1.28

0.57

1.3

1.2

—

nmol/l

—

Superficial injury of shoulder and upper arm

463

0.82

0.57

1.1

1.3

—

nmol/l

—

Carcinoma in situ of skin of ear and external auricular canal

1.68

0.57

1.3

1.1

—

nmol/l

—

Graves ophthalmopathy, strict

1.44

0.56

1.1

1.3

—

nmol/l

—

Alzheimer disease, excluding more controls

390

0.84

0.56

1.2

1.3

—

nmol/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

141

1.35

0.56

1.1

1.2

—

nmol/l

—

Acquired haemolytic anaemia

1.51

0.56

1.8

1.3

—

Adhesive middle ear disease

1.46

0.56

1.4

1.3

—

Benign neoplasm of other and unspecified intrathoracic organs

1.63

0.56

2.3

1.3

—

nmol/l

—

Fasciculation

1.63

0.55

1.2

1.3

—

nmol/l

—

Disorders of porphyrin and bilirubin metabolism

1.63

0.55

1.3

1.4

—

nmol/l

—

Alcoholic gastritis

1.63

0.55

1.2

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

309

0.82

0.55

1.2

1.3

—

nmol/l

—

Conductive hearing loss, unspecified

311

1.22

0.55

1.2

1.3

—

nmol/l

—

Burn and corrosion of trunk

1.45

0.55

1.1

1.3

—

nmol/l

—

Follicular lymphoma

159

1.33

0.55

1.1

1.3

—

nmol/l

—

Palmar fascial fibromatosis [Dupuytren]

551

1.16

0.55

1.2

1.3

—

nmol/l

—

Maternal care for cervical incompetence

177

1.30

0.54

1.0

1.3

—

nmol/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

151

917

1.10

0.54

1.2

—

nmol/l

—

Systemic atrophies primarily affecting the central nervous system

124

0.64

0.54

1.1

1.2

—

Intracranial and intraspinal abscess and granuloma

1.59

0.54

1.5

1.3

—

nmol/l

—

Injury of muscle and tendon at ankle and foot level

1.47

0.54

1.1

1.3

—

nmol/l

—

Tic and related disorders

1.59

0.54

1.0

1.2

—

nmol/l

—

Abscess of lung

1.59

0.54

1.3

—

nmol/l

—

Obstructive hydrocephalus

1.59

0.54

1.3

—

nmol/l

—

Benign neoplasm: Tongue

1.42

0.54

1.0

1.3

—

nmol/l

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

413

1.19

0.54

1.4

1.3

—

nmol/l

—

Rheumatic valve diseases

1.48

0.53

1.2

1.3

—

Other/unspecified reactive arthropathies

240

1.25

0.53

1.2

1.3

—

nmol/l

—

Left ventricular outflow tract obstruction, narrow definition

160

1.32

0.53

1.0

1.3

—

nmol/l

—

Benign neoplasm: Conjunctiva

108

1.39

0.53

1.1

1.3

—

nmol/l

—

Sixth [abducent] nerve palsy

108

1.39

0.53

1.1

1.3

—

nmol/l

—

Disorders of optic nerve, not elsewhere classified

1.46

0.53

1.1

1.2

—

nmol/l

—

Other and unspecified acne

1.54

0.53

1.0

1.5

—

nmol/l

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

1.43

0.53

1.6

1.2

—

nmol/l

—

Recurrent dislocation of patella

178

1.30

0.53

1.2

1.4

—

nmol/l

—

Carcinoma in situ of skin of lower limb, including hip

1.52

0.52

1.2

—

nmol/l

—

Postpartum haemorrhage due to anatomy

382

0.81

0.52

1.9

1.2

—

nmol/l

—

Other and unspecified nail disorders

1.52

0.52

1.2

1.3

—

Benign neoplasm: Skin of trunk

152

1.32

0.52

1.4

1.3

—

nmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

133

0.67

0.52

2.0

1.3

—

nmol/l

—

Secondary parkinsonism

1.45

0.52

1.3

—

Scissor bite

1.51

0.52

1.0

1.4

—

nmol/l

—

Acute posthaemorrhagic anaemia

100

1.40

0.52

1.9

1.2

—

nmol/l

—

Other acute disseminated demyelination

1.51

0.52

1.5

1.3

—

Colon adenocarcinoma

415

1.18

0.52

1.4

1.3

—

nmol/l

—

Other acute viral hepatitis

1.51

0.51

1.7

1.3

—

nmol/l

—

Other disorders of optic disc

1.51

0.51

1.2

1.1

—

nmol/l

—

Beningn neoplasm: Meninges, unspecified

1.41

0.51

1.2

1.3

—

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

126

1.35

0.51

1.3

—

nmol/l

—

Lymphoid leukaemia

179

1.29

0.51

1.5

1.3

—

nmol/l

—

Malignant neoplasm of bladder

179

1.29

0.51

1.2

1.3

—

nmol/l

—

Traumatic amputation of wrist and hand

135

1.34

0.51

1.4

—

nmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

251

1.24

0.51

1.1

1.3

—

nmol/l

—

Sulfasalazine

155

1418

1.09

0.51

1.2

1.3

—

nmol/l

—

Viral conjunctivitis

1.47

0.51

1.0

1.3

—

nmol/l

—

Mild mental retardation

1.47

0.51

1.2

1.3

—

Beningn neoplasm: Meninges, unspecified

1.39

0.50

1.2

1.3

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

144

1.32

0.50

1.1

1.4

—

nmol/l

—

ILD, hospital admission 2, with pulmonary infections

306

1.21

0.50

1.6

1.3

—

nmol/l

—

Benign neoplasm: Skin of trunk

153

1.31

0.50

1.4

1.3

—

nmol/l

—

Ankylosing spondylitis, ICD10

352

1.20

0.50

1.3

—

nmol/l

—

Complications following abortion and ectopic and molar pregnancy

171

1.29

0.50

1.1

1.3

—

nmol/l

—

Behavioural disorders

1.50

0.50

1.3

1.4

—

nmol/l

—

Chronic viral hepatitis

189

1.27

0.49

1.4

1.3

—

nmol/l

—

Benign neoplasm of major salivary glands

408

1.18

0.49

1.2

1.3

—

nmol/l

—

Diabetic retinopathy, strict definition

107

845

1.11

0.49

1.2

1.4

—

nmol/l

—

Lack of expected normal physiological development

1.57

0.49

1.0

1.1

—

nmol/l

—

Use of selegiline

136

1.33

0.49

1.4

1.3

—

nmol/l

—

ILD, hospital admissions

548

1.15

0.49

1.5

1.3

—

nmol/l

—

Contact with other hot metals

1.56

0.49

1.4

—

nmol/l

—

Vasomotor rhinitis (mode)

298

1.21

0.49

1.2

1.3

—

nmol/l

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

312

0.80

0.48

1.2

1.3

—

nmol/l

—

Shoulder region

1.53

0.48

1.0

1.3

—

nmol/l

—

Lichen simplex chronicus and prurigo

262

1.22

0.48

1.3

—

nmol/l

—

Drug-induced hypoglycaemia without coma

1.53

0.48

1.0

1.3

—

nmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

363

1.19

0.48

1.3

—

nmol/l

—

Opening and dilatation of root channel of tooth

244

1.23

0.48

1.1

1.3

—

nmol/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

235

1.24

0.48

1.0

1.3

—

nmol/l

—

Infection due to other mycobacteria

1.50

0.47

1.4

1.3

—

nmol/l

—

Other and unspecified haemorrhagic conditions

1.50

0.47

1.1

1.3

—

Interstitial lung disease endpoints

550

1.15

0.47

1.5

1.3

—

nmol/l

—

Other interstitial pulmonary diseases

550

1.15

0.47

1.5

1.3

—

nmol/l

—

Interstitial lung disease

550

1.15

0.47

1.5

1.3

—

nmol/l

—

Cytomegalovirus infection, IBD co-morbidity

1.48

0.47

1.3

1.1

—

nmol/l

—

1.48

0.47

1.3

—

Other diseases caused by chlamydiae

1.47

0.47

1.1

1.3

—

Adenocarcinoma of pancreas

1.42

0.47

1.0

1.2

—

nmol/l

—

Xerosis cutis

1.43

0.46

1.0

1.3

—

nmol/l

—

Dermatopolymyositis (FG)

1.43

0.46

1.0

1.3

—

nmol/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.43

0.46

1.4

1.5

—

nmol/l

—

Valvular operations

486

1.15

0.46

1.6

1.3

—

nmol/l

—

Supervision of normal pregnancy

605

0.90

0.45

1.2

1.3

—

nmol/l

—

Premature separation of placenta [abruptio placentae]

1.43

0.45

1.2

—

nmol/l

—

Mental retardation, wide definition

129

1.32

0.45

1.2

1.3

—

nmol/l

—

Hereditary corneal dystrophies

121

0.66

0.45

1.1

1.2

—

nmol/l

—

Congenital malformations of aortic and mitral valves

138

1.31

0.45

1.1

1.3

—

nmol/l

—

Rubella [German measles]

121

0.66

0.45

1.1

1.3

—

Keratoconus

0.59

0.45

1.0

1.4

—

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.40

0.45

1.0

1.4

—

Oral leukoplakia and related diseases, including avohilmo

366

1.18

0.45

1.3

—

nmol/l

—

Benign neoplasm: Conjunctiva

112

1.34

0.44

1.1

1.3

—

nmol/l

—

Parkinson's disease

553

1.14

0.44

1.5

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia

1.40

0.44

1.3

—

nmol/l

—

Tuberculosis, IBD comorbidity

238

1.22

0.44

1.5

1.2

—

nmol/l

—

Other epidermal thickening

148

1.29

0.43

1.1

1.2

—

nmol/l

—

Right hemicolectomy

202

1.24

0.43

1.2

—

nmol/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.62

0.43

1.0

1.1

—

nmol/l

—

Tarsal tunnel syndrome

1.62

0.43

1.0

1.2

—

Other injuries of upper limb, level unspecified

1.62

0.43

1.4

1.2

—

nmol/l

—

Disorders of tooth development and eruption

153

1.27

0.43

1.2

—

nmol/l

—

Other degenerative diseases of the nervous system

113

780

1.10

0.42

1.2

1.3

—

nmol/l

—

Systemic sclerosis,strict definition

1.57

0.42

1.6

1.2

—

Disease of hard tissues of teeth, NOS

1.57

0.42

1.2

—

nmol/l

—

Congenital malformations of the respiratory system

1.41

0.42

1.4

1.3

—

nmol/l

—

Carcinoma in situ of skin of lower limb, including hip

1.44

0.42

1.2

1.1

—

nmol/l

—

Primary angle-closure glaucoma

149

1.28

0.42

1.5

1.2

—

nmol/l

—

Encephalitis

1.36

0.41

1.1

1.2

—

nmol/l

—

Other and unspecified degenerative diseases of nervous system

1.38

0.41

1.1

1.2

—

nmol/l

—

Other and unspecified localized connective tissue disorders

0.00

0.41

0.0

1.2

—

Androgenic alopecia

1.52

0.41

1.0

1.2

—

Osteomalacia

1.52

0.41

1.2

1.5

—

Congenital malformations of gallbladder, bile ducts and liver

1.52

0.41

1.4

—

nmol/l

—

Mucinous and mucinous cystic tumor

0.00

0.41

0.0

1.1

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.41

0.0

1.6

—

Listeriosis

0.00

0.41

0.0

1.6

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.7

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.41

0.0

1.1

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.6

—

ILD medications: nintedanib

0.00

0.41

0.0

1.3

—

Diabetic retinopathy

210

1240

1.07

0.41

1.3

1.4

—

nmol/l

—

Alzheimer’s disease (undefined)

0.00

0.41

0.0

1.1

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

1.36

0.41

1.6

1.2

—

Other/unspecified cytomegaloviral diseases

1.36

0.41

1.4

1.3

—

nmol/l

—

Streptococcal septicaemia

277

1.19

0.41

1.1

1.3

—

nmol/l

—

Viral encephalitis, not elsewhere classified/unspecified

1.36

0.41

1.1

1.2

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.41

0.0

1.5

—

Implicit parasitic Sepsis

0.00

0.41

0.0

1.3

—

Anomalies of pupillary function

1.40

0.41

1.4

—

nmol/l

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.41

0.0

1.1

—

Cleft lip and palate

0.00

0.41

0.0

1.6

—

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.4

—

Corns and callosities

268

1.20

0.41

1.2

1.3

—

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

1.40

0.40

1.4

1.2

—

nmol/l

—

Glaucoma-related operations

204

1.23

0.40

1.2

—

nmol/l

—

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

1.48

0.40

1.0

1.2

—

nmol/l

—

Other forms of systemic lupus erythematosus

1.48

0.40

1.8

1.1

—

nmol/l

—

ILD, hospital admissions 1, main diag only

492

1.14

0.40

1.6

1.3

—

nmol/l

—

Colitis, primary sclerosing, strict definition

1.48

0.40

1.2

—

nmol/l

—

Use of teriflunomide

1.48

0.40

1.0

1.1

—

Other autoimmune haemolytic anaemias

1.48

0.40

1.4

—

1.48

0.40

1.2

1.3

—

nmol/l

—

Other and unspecified atrophic disorders of skin

0.00

0.40

0.0

1.2

—

Chromosomal abnormalities, not elsewhere classified

1.33

0.40

1.3

1.4

—

nmol/l

—

Burn and corrosion, body region unspecified

0.00

0.40

0.0

1.2

—

Thrombotic microangiopathy

0.00

0.40

0.0

1.6

—

Non-seminoma of testis

0.00

0.40

0.0

1.3

—

Campylobacter enteritis

1.37

0.40

1.1

1.3

—

Use of entacapone

0.00

0.40

0.0

1.2

—

Pathological resorption of teeth

1.37

0.40

1.2

1.1

—

nmol/l

—

Tuberculosis, wide

241

1.21

0.40

1.5

1.2

—

nmol/l

—

Open wound of lower leg

587

1.13

0.40

1.3

—

nmol/l

—

Iridocyclitis in diseases classified elsewhere

1.32

0.39

1.5

1.3

—

nmol/l

—

Malignant neoplasm of tongue

1.32

0.39

1.3

—

nmol/l

—

Other bursitis of hip

1.31

0.39

1.0

1.3

—

nmol/l

—

Atypical virus infections of central nervous system

1.43

0.39

1.0

1.3

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.43

0.39

1.0

1.4

—

nmol/l

—

Benign neoplasm: Orbit, unspecified

0.00

0.39

0.0

1.5

—

Mandibular hypoplasia

0.00

0.39

0.0

1.1

—

Pneumonia due to other infectious organisms, not elsewhere classified

106

1.32

0.39

1.1

1.3

—

nmol/l

—

Benign mammary dysplasia

721

1.11

0.39

1.3

—

nmol/l

—

Hordeolum and other deep inflammation of eyelid

196

1.23

0.39

1.2

1.3

—

nmol/l

—

Monoarthritis, not elsewhere classified

151

1.26

0.38

1.2

1.4

—

nmol/l

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

159

0.75

0.38

1.1

1.3

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.37

0.38

1.6

1.2

—

nmol/l

—

Crushed, pushed or stepped on by crowd or human stampede

270

1.19

0.38

1.0

1.3

—

nmol/l

—

Reactive arthropathies

363

1.16

0.38

1.2

1.3

—

nmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.39

0.38

1.4

1.2

—

nmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.39

0.38

1.4

1.2

—

nmol/l

—

Venous complications and haemorrhoids in the puerperium

1.39

0.38

1.2

—

Pedestrian injured in other and unspecified transport accidents

1.39

0.38

1.6

1.4

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.39

0.38

2.2

1.2

—

Ankyloglossia

1.39

0.38

1.0

1.3

—

nmol/l

—

1.39

0.38

1.0

1.1

—

nmol/l

—

Parkinson's disease, including avohilmo

580

1.12

0.38

1.5

1.3

—

nmol/l

—

Alzheimer’s disease, wide definition, excluding more controls

337

0.87

0.38

1.2

1.3

—

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.33

0.37

1.9

1.3

—

Other superficial mycoses

1.33

0.37

2.4

1.3

—

nmol/l

—

Amputation of foot

1.33

0.37

1.6

1.2

—

nmol/l

—

Generalized epilepsy, strict definition

1.33

0.37

1.3

—

nmol/l

—

Other specified/unspecified systemic involvement of connective tissue

243

1.20

0.37

1.6

1.2

—

nmol/l

—

Varicose veins of other sites

243

1.20

0.37

1.3

—

nmol/l

—

Malignant neoplasm of vulva

1.36

0.37

1.8

1.2

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

107

1.31

0.37

1.2

1.3

—

nmol/l

—

Burn and corrosion of ankle and foot

1.35

0.37

1.2

1.3

—

nmol/l

—

Dislocation, sprain and strain of joint and ligaments of hip

115

0.69

0.37

1.0

1.3

—

nmol/l

—

Bilateral sagittal split ramus osteotomy operation

125

1.28

0.37

1.3

1.4

—

nmol/l

—

Cytomegaloviral disease

1.39

0.37

1.3

—

nmol/l

—

Retinal haemorrhage

1.39

0.37

1.2

1.3

—

nmol/l

—

Juvenile rheumatoid arthirtis

1.39

0.37

1.0

1.5

—

nmol/l

—

Other specified and unspecified disorders of eye and adnexa

134

1.27

0.37

1.2

1.3

—

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

374

1.15

0.36

1.3

1.2

—

nmol/l

—

Coronary angioplasty

172

1235

1.07

0.36

1.3

—

nmol/l

—

HSIL lesion of the vulva

1.27

0.36

1.1

1.2

—

nmol/l

—

Benign neoplasm: Spinal meninges

1.47

0.36

1.8

1.3

—

Viral infections of central nervous system, not elsewhere classified/unspecified

1.47

0.36

1.0

1.3

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.45

0.36

1.0

1.1

—

nmol/l

—

Combined immunodeficiencies

1.44

0.35

1.3

—

nmol/l

—

Diseases caused by chlamydiae

1.43

0.35

1.0

1.4

—

Varus deformity, not elsewhere classified

1.43

0.35

1.0

1.5

—

Other congenital malformations of the digestive system

134

1.26

0.35

1.5

1.2

—

nmol/l

—

Colitis, primary sclerosing

1.40

0.35

1.2

—

nmol/l

—

Morphin

1.40

0.35

2.0

1.2

—

Dementia due to Parkinsons disease, excluding more controls

1.40

0.35

1.3

1.2

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

236

1.19

0.35

1.1

1.4

—

nmol/l

—

Spirochaetal infections, other/unspecified

348

1.15

0.34

1.3

—

nmol/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.37

0.34

1.2

1.5

—

nmol/l

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

1.37

0.34

1.2

—

Other benign neoplasm of uterus: Other parts/unspecified

172

1.22

0.34

1.2

1.3

—

nmol/l

—

Antenatal screening

102

625

0.92

0.34

1.2

1.3

—

nmol/l

—

Carcinoma in situ of other and unspecified digestive organs

1.35

0.34

1.3

1.2

—

nmol/l

—

Infective bursitis

1.35

0.34

1.4

—

nmol/l

—

Benign neoplasm: Spinal meninges

1.34

0.34

1.8

1.3

—

Benign neoplasm: Bronchus and lung

1.34

0.34

1.0

1.3

—

nmol/l

—

Benign neoplasm: Skin of lip

1.34

0.34

1.5

1.4

—

nmol/l

—

Use of ropinirole

127

1.26

0.33

1.6

1.3

—

nmol/l

—

Serous carcinoma of ovary

155

0.77

0.33

1.1

1.3

—

Other abnormalities of plasma proteins

1.31

0.33

1.5

1.2

—

nmol/l

—

Disorders in reading

1.31

0.33

1.8

1.4

—

nmol/l

—

Alcohol abuse, main dg, excluding more controls

558

1.11

0.33

1.3

—

nmol/l

—

Benign neoplasm: Bronchus and lung

1.28

0.32

1.0

1.3

—

nmol/l

—

Chronic hepatitis NAS

1.28

0.32

1.0

1.3

—

Other degenerative diseases of the basal ganglia

1.28

0.32

1.0

1.3

—

nmol/l

—

Portal vein thrombosis

1.28

0.32

1.0

1.3

—

nmol/l

—

Mandibular prognathia

1.28

0.32

1.7

1.3

—

nmol/l

—

Unspecified jaundice

137

1.24

0.32

1.6

1.3

—

nmol/l

—

Motorcycle rider injured in noncollision transport accidents

1.31

0.32

1.2

1.3

—

Mumps

101

1.29

0.32

1.2

1.3

—

nmol/l

—

Injury of muscle and tendon at lower leg level

617

1.10

0.31

1.2

1.3

—

nmol/l

—

Memory loss

348

0.86

0.31

1.2

1.3

—

nmol/l

—

Parkinson's disease, strict definition

503

1.11

0.31

1.5

1.3

—

nmol/l

—

Crossbite

204

1.18

0.31

1.2

—

nmol/l

—

Third [oculomotor] nerve palsy

1.35

0.31

1.9

1.4

—

Unspecified acute lower respiratory infection

570

1.11

0.31

1.4

1.3

—

nmol/l

—

Status post-ami

135

0.79

0.31

1.2

—

Hodgkin lymphoma, hilmo

0.72

0.31

1.1

1.3

—

nmol/l

—

Congenital malformations of breast

1.32

0.31

1.6

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

258

1.16

0.31

1.7

1.3

—

nmol/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

248

1625

1.05

0.31

1.3

1.2

—

nmol/l

—

Meningitis

193

1.19

0.30

1.2

1.3

—

nmol/l

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

100

0.70

0.30

1.0

1.4

—

Other deformities of toe(s)

138

1.23

0.30

1.2

1.3

—

nmol/l

—

Corneal degeneration

1.30

0.30

1.0

1.3

—

nmol/l

—

Other bursal cyst

1.30

0.30

1.1

1.3

—

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.30

0.30

1.0

1.3

—

Benign neoplasm of male genital organs

1.30

0.30

1.6

1.3

—

nmol/l

—

Degeneration of the brain due to alcohol

1.30

0.30

1.4

1.3

—

Special screening examination for neoplasms

120

1.25

0.30

1.7

1.2

—

nmol/l

—

Carcinoma in situ of other and unspecified digestive organs

1.31

0.30

1.3

1.2

—

nmol/l

—

Use of amantadine

1.28

0.30

1.1

1.3

—

nmol/l

—

Dental caries 1 and operation codes, only avohilmo

170

805

1.06

0.30

1.3

—

nmol/l

—

Degeneration of nervous system due to alcohol

1.28

0.30

1.4

1.3

—

Dermatopolymyositis

1.25

0.29

1.0

1.3

—

nmol/l

—

Dissocial personality disorder

1.25

0.29

1.0

1.5

—

nmol/l

—

Toxic effect of carbon monoxide

1.25

0.29

1.6

1.3

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.23

0.29

1.1

1.3

—

Colorectal adenocarcinoma

765

1.09

0.29

1.3

—

nmol/l

—

malignant neoplasm of female genital organs

756

1.09

0.28

1.2

1.3

—

nmol/l

—

Foreign body entering into or through eye or natural orifice

291

0.86

0.28

1.2

1.3

—

nmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

140

0.78

0.28

1.2

1.3

—

nmol/l

—

Struck by thrown, projected or falling objec

158

1.20

0.28

1.0

1.4

—

nmol/l

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.29

0.28

1.1

1.4

—

nmol/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

149

1.21

0.28

1.3

1.4

—

nmol/l

—

Other retinal artery occlusion

1.27

0.28

1.4

1.3

—

Pyoderma

1.25

0.27

1.1

1.4

—

nmol/l

—

Vascular dementia (subcortical)

1.25

0.27

1.1

1.2

—

nmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

121

0.74

0.27

2.0

1.3

—

nmol/l

—

Orthopaedic devices associated with adverse incidents

1.23

0.27

1.0

1.2

—

Stenosis and insufficiency of lacrimal passages

394

1.12

0.27

1.2

1.3

—

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

356

1.13

0.27

1.1

1.3

—

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

309

1.13

0.27

1.1

1.3

—

nmol/l

—

Viral pneumonia (known virus, not influenza)

1.21

0.26

1.5

1.3

—

nmol/l

—

Cirrhosis of liver, NAS

159

1.20

0.26

1.5

1.3

—

nmol/l

—

Mixed connective tissue disease

281

1.14

0.26

1.6

1.2

—

nmol/l

—

Torsion of testis

1.20

0.26

1.0

1.5

—

nmol/l

—

Contact with other hot fluids

1.27

0.26

1.2

1.3

—

nmol/l

—

Chronic Coagulation defects

1.28

0.26

1.5

1.2

—

nmol/l

—

Lichen simplex chronicus

141

1.21

0.26

1.4

1.3

—

nmol/l

—

Exposure to smoke, fire and flames

0.67

0.26

1.0

1.3

—

nmol/l

—

Use of levodopa decarboxylase inhibitor

472

1.10

0.26

1.5

1.3

—

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

251

1650

1.04

0.25

1.4

1.2

—

nmol/l

—

Testicular hypofunction

1.25

0.25

1.3

1.1

—

Benign neoplasm: Skin of upper limb, including shoulder

1.24

0.25

1.9

1.3

—

Chronic hepatitis, not elsewhere classified

123

1.22

0.25

1.1

1.2

—

nmol/l

—

Squamous cell neoplasms and carcinomas of the skin

377

1.11

0.25

1.5

1.3

—

nmol/l

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

1.22

0.25

1.1

1.3

—

nmol/l

—

Haemolytic anaemias

114

1.23

0.25

1.7

1.2

—

nmol/l

—

Osteomyelitis

207

1.16

0.25

1.3

—

nmol/l

—

Chronic suppurative otitis media, including avohilmo

292

1.13

0.25

1.2

1.3

—

nmol/l

—

Chorioretinal inflammation

105

1.24

0.25

1.1

1.3

—

nmol/l

—

Benign neoplasm: Lip

1.19

0.24

1.0

1.2

—

nmol/l

—

Coronary artery bypass grafting

781

0.93

0.24

1.3

—

nmol/l

—

Disorders of globe

1.19

0.24

1.4

—

nmol/l

—

Unspecified dementia

259

0.87

0.24

1.2

1.3

—

nmol/l

—

Oral leukoplakia, including avohilmo

1.25

0.24

1.2

1.3

—

nmol/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

242

1602

1.04

0.24

1.3

1.2

—

nmol/l

—

Carcinoma in situ of other and unspecified genital organs

1.17

0.24

1.2

—

nmol/l

—

Enteropathic arthropathies

1.27

0.24

1.1

1.4

—

nmol/l

—

Other localized connective tissue disorders

1.17

0.24

1.6

1.3

—

nmol/l

—

Problems related to social environment

0.74

0.24

1.7

1.2

—

nmol/l

—

Agranulocytosis

484

1.10

0.24

1.7

1.3

—

nmol/l

—

Other abnormal auditory perceptions

1.32

0.23

1.4

—

nmol/l

—

Recurring oral aphthae

171

1.17

0.23

1.7

1.3

—

nmol/l

—

Anisometropia and aniseikonia

106

1.23

0.23

1.3

—

Chronic ulcer of skin, not elsewhere classified

237

1.14

0.23

1.4

1.2

—

nmol/l

—

Benign neoplasm: Appendix

1.29

0.23

1.2

—

nmol/l

—

Benign neoplasm: Appendix

1.29

0.23

1.2

—

nmol/l

—

Diabetic neuropathy

521

1.09

0.23

1.2

1.4

—

nmol/l

—

Primary coxarthrosis, bilateral

138

1311

1.05

0.22

1.3

—

nmol/l

—

Subarachnoid haemorrhage

409

1.10

0.22

1.5

1.3

—

nmol/l

—

Prolapse and hernia of ovary and fallopian tube

145

0.82

0.22

1.3

1.1

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

1.25

0.22

1.2

—

nmol/l

—

Other disorders of iris and ciliary body

1.25

0.22

1.0

1.2

—

nmol/l

—

Major anomalies of jaw size

0.77

0.22

1.1

1.3

—

nmol/l

—

Hodgkin lymphoma

0.75

0.22

1.1

1.3

—

nmol/l

—

Other and unspecified mental retardation

1.22

0.22

1.0

1.3

—

nmol/l

—

Telogen effluvium

0.00

0.21

0.0

1.2

—

Cyst of spleen

0.00

0.21

0.0

1.7

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.1

—

Crushing injury of lower leg

0.00

0.21

0.0

1.2

—

Benign neoplasm: Vertebral column

0.00

0.21

0.0

1.7

—

Plasmodium falciparum malaria

0.00

0.21

0.0

1.8

—

Chronic inflammatory disorders of orbit

0.00

0.21

0.0

1.7

—

Cerebral arteritis

0.00

0.21

0.0

1.0

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.19

0.21

2.8

1.3

—

nmol/l

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.3

—

Hypertension, portal

0.00

0.21

0.0

1.8

—

Other and unspecified syphilis

0.00

0.21

0.0

2.5

—

Atypical mycobacterium lung infection

1.19

0.21

1.6

1.4

—

nmol/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.1

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.19

0.21

1.8

1.2

—

nmol/l

—

Labyrinthine fistula

0.00

0.21

0.0

1.1

—

Contracture of joint

1.19

0.21

1.4

1.3

—

nmol/l

—

Use of riluzole

0.00

0.21

0.0

1.1

—

Acanthosis nigricans

0.00

0.21

0.0

1.2

—

Erectile dysfunction, exclusion

0.00

0.21

0.0

1.1

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.8

—

Actinomycosis

0.00

0.21

0.0

1.2

—

Acute thyroiditis

0.00

0.21

0.0

1.1

—

Testicular dysfunction, other/unspecified

0.00

0.21

0.0

1.1

—

Malignant neoplasm of anus and anal canal

0.00

0.21

0.0

1.3

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

0.21

0.0

1.2

—

Molar incisor enamel hypoplasia, with caries

0.00

0.21

0.0

1.2

—

Cicatricial pemphigoid

0.00

0.21

0.0

1.8

—

Exposure to uncontrolled fire, not in building or structure

0.00

0.21

0.0

1.8

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.2

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.6

—

Monocytic leukaemia

0.00

0.21

0.0

1.2

—

Maxillary hypoplasia

0.00

0.21

0.0

1.7

—

Other cestode infections

0.00

0.21

0.0

1.8

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.21

0.0

1.2

—

Septal defects

215

1.14

0.21

2.3

1.3

—

nmol/l

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.21

0.0

1.2

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.1

—

Hypoplasia of dental enamel, including avohilmo

0.00

0.21

0.0

1.2

—

Erosion and ectropion of cervix uteri

126

1.19

0.21

1.3

1.1

—

nmol/l

—

Lichenoid drug reaction

0.00

0.21

0.0

1.3

—

Coronary revascularization (ANGIO or CABG)

220

1477

1.04

0.21

1.3

—

nmol/l

—

Choroidal haemorrhage and rupture

0.00

0.21

0.0

1.6

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

0.21

0.0

1.2

—

Burn and corrosion of other internal organs

0.00

0.21

0.0

1.5

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.2

—

Sequelae of transport accidents

0.00

0.21

0.0

1.5

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Metanephrine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS